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Background and Introduction
Despite significant declines in maternal mortality rates, sub-Saharan Africa continues to face the burden of
maternal deaths due to pregnancy related complications. Nigeria is one of the ten most dangerous countries for
a woman giving birth and is reportedly responsible for 14% of the world’s maternal deaths (National Population
Commission [Nigeria] & ICF International, 2014). Nigeria’s MMR is estimated to be 576 deaths per 100,000 live
births; one in 30 women in Nigeria will die from a cause related to pregnancy or childbirth (NPC & ICF
International, 2014). Poor health systems, lack of trained staff and quality of care, low levels of education,
poverty, patriarchal societies and women's lack of agency to make decisions about their own healthcare needs
are some of the factors contributing to the high maternal mortality and morbidity (NPC & ICF International, 2014)
Pre-eclampsia and eclampsia (PE/E), pregnancy-related hypertensive disorders, are consistently cited as a
leading cause of maternal morbidity and mortality Nigeria. In addition to maternal morbidity and mortality, PE/E
can increase the likelihood of preterm or stillbirth (Onyearugha, & Ugboma, 2012; Olusanya & Solanke, 2012b;
Owolabi et al., 2008). Both PE/E are preventable and the deaths due to PE/E can be avoided through timely
detection and management of complications during and after pregnancy (The World Health Organization, 2011).
To fully appreciate the enormity of the problem at country level, we conducted a systematic review of published
papers on PE/E in Nigeria from 2000-2015 in order to understand the key challenges, gaps and interventions
related to the prevention and treatment of pre-eclampsia and eclampsia.

WHAT IS PRE-ECLAMPSIA AND ECLAMPSIA?
While the medical cause of eclampsia is unknown and definitions of the condition vary, there are some generallyaccepted signs and symptoms that are used to diagnose pre-eclampsia and eclampsia in pregnant women. Preeclampsia is a condition where a woman experiences a rapid elevation of blood pressure to > 140/90 mmHg
(hypertension) and high levels of protein in the urine (significant proteinuria >0.3g/day or >30mg/mmol of
urinary creatinine in random sample) after 20 weeks gestation (Magee et al., 2015). If untreated, it can progress
to eclampsia, characterized by seizures, and other complications such as kidney or liver damage and ultimately
death of the mother and/or fetus.
Diagnosing pre-eclampsia and managing it before it progresses to severe pre-eclampsia or eclampsia is a critical
strategy to promote maternal and newborn health. Pre-eclampsia can be managed and eclampsia can be
prevented by routine screening of blood pressure and protein levels in urine for pregnant women during
antenatal care (ANC) visits. Health care providers can manage high BP in pregnant women using antihypertensive
drugs that are safe during pregnancy, prevent and control eclamptic convulsions with injectable magnesium
sulphate (MgSO4) and, if at PHC facility, should refer the woman for follow-up monitoring and management of
PE/E.
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FIGURE 1 Diagnosing pre-eclampsia and eclampsia

Adapted from: Wagner, L.K. (2004)

The World Health Organization (WHO) recommends three main evidence-based approaches to prevent maternal
mortality due to PE/E (The World Health Organization, 2011):
1) Preventing the incidence of PE/E by screening all pregnant women for signs and symptoms during
antenatal care (ANC) check-ups. Preventative interventions include: calcium supplementation during
pregnancy, low-dose aspirin prophylaxis and family planning methods to delay pregnancies.
2) Detecting early signs of PE by measuring blood pressure and protein levels in the urine during ANC visits
to monitor and manage pre-eclampsia.
3) Managing severe cases of PE/E by administering anti-convulsant therapy―magnesium sulphate
(MgSO4) ―to stop seizures followed by careful monitoring of the pregnant mother and her fetus and plan
timed delivery of the baby.
The World Health Organization recommends use of MgSO4 as the standard method of preventing eclampsia in
women with severe pre-eclampsia and of treating eclampsia (The World Health Organization, 2011). Women
treated with MgSO4 have a 67% lowered risk of recurrent seizures compared to women who were treated with
diazepam and phenytoin (Euser & Cipolla, 2009). Despite its proven efficacy, this inexpensive drug is often
underutilized for various reasons including lack of awareness and continued use of outdated methods (like
diazepam and phenytoin), poor access to supplies, and insufficient number of trained personnel to administer
MgSO4 (Yeager & Patel, 2012).
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PRE-ECLAMPSIA AND ECLAMPSIA IN NIGERIA
In Nigeria, approximately 34% of pregnant women receive no antenatal care, putting them at higher risk of
maternal mortality (NPC & ICF International, 2014). A recent, nationwide cross-sectional survey found that preeclampsia and eclampsia is the leading cause of maternal mortality in Nigeria and is responsible for 28.2% of
maternal deaths; the other main contributors to maternal mortality are hemorrhage (24.4%) and pregnancyrelated infection/sepsis (14.2%) (Oladapo et al., 2015).
This systematic review of peer-reviewed literature published after 2000 aims to identify the interventions
adopted to treat and manage pre-eclampsia and eclampsia. It specifically looks at issues around the quality of
care, gaps in the evidence, and barriers to accessing services for PE/E in Nigeria.

NIGERIAN HEALTH SYSTEM AND MATERNAL HEALTH POLICIES
Nigeria is Africa’s most populous nation of 162.5 million people. The Nigerian health system divides hospitals
into primary, secondary, and tertiary hospitals with referral linkages between them (Tukur et al, 2009). In
addition, Nigeria divides levels of governance into three distinct and independent entities, which are: federal,
state, and local governments. The tertiary healthcare systems are managed by the federal government, the
secondary institutions by the state government and the primary health care by the local government authorities,
with no formal connection between these levels of care (Tukur et al, 2009). Patients with Pre-eclampsia and
eclampsia are often referred from primary to secondary and tertiary health facilities for management. Delays in
care are common due to lack of knowledge from the patient and poor understanding of the seriousness of the
condition, as well as differing governance structures in the healthcare system.
Some of the key national policies and strategies adopted in Nigeria to address the high MMR include: Safe
Motherhood Initiative launched in Nairobi in 1987, the road map for accelerating the attainment of MDG 4 and
MDG 5 in 2005, FIGO's Safe Motherhood and Newborn Health Committee Initiative (2006-2011), the Integrated
Maternal Newborn and Child Health (MNCH) Strategy in 2007, the Midwives Services Scheme (2009) which was
launched by the National Primary Healthcare Development agency, USAID’s Saving Mothers, Giving Life initiative
(2012) and their Maternal and Child Survival Program (MCSP) and DFID’s Maternal and Newborn Child Health
Programme. The Federal Ministry of Health has included all of the necessary drugs for the management of
hypertensive disorders of pregnancy (Labetalol, Hydralazine, Methyldopa, Nifedipine, magnesium sulphate, and
calcium gluconate), on the national Essential Medicines List (EML) which was last updated in 2010 (Federal
Ministry of Health Nigeria, 2010). The inclusion of these drugs on the EML means that every facility should
maintain a regular supply of these medications; though this is not always the case. While some of these efforts
have put a focus on the high maternal mortality rate in Nigeria, much remains to be done to address some of
the challenges in the delivery of services for the prevention and treatment of pre-eclampsia/eclampsia. It will be
necessary to re-visit some of the policies and on-going programs and explore how we may improve some of the
gaps in health management to achieve better maternal health.
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Methods
This systematic literature review was conducted in three phases to collect, organize and analyze the published
literature on pre-eclampsia and eclampsia in Nigeria.

IDENTIFYING ARTICLES FOR REVIEW
Search of Databases
The research team developed two sets of key terms related to pre-eclampsia and eclampsia that captured
citations for peer-reviewed papers related to detection, management, and prevention of PE/E (Appendix I). The
first search was designed to capture results that do not mention PE/E explicitly and the second search included
the MeSH terms for PE/E and the rare complication known as, HELLP syndrome. The two searches were run in
bibliographic databases including: PubMed, ScienceDirect, World of Science, Cochrane, POPLINE, and Wiley
Online Library. These searches used a combination of terms linking various aspects of the diagnosis, treatment,
and prevention of pre-eclampsia, eclampsia and hypertensive disorders of pregnancy. Searches were limited to
articles published from 2000 to 2015 (April).
To accommodate the large number of key terms included in the second search, the terms were divided into three
sub-searches to avoid any inadvertent omissions. The exact combinations of search terms used can also be
found in Appendix I. The three sub-searches resulted in a high volume of duplicate citations.

Google Search
In an effort to identify any articles that may have been missed during the database searches, a simple google
search was done using the following search terms:
"eclampsia" or "pre eclampsia" or "preeclampsia" or "pre-eclampsia" AND Nigeria
From the articles identified, the same search was run on the website or database hosting those articles. These
sites included: Hindawi.com, African Journals Online (AJOL), Journal of Obstetrics and Gynaecology Canada
(JOGC), Journal of Family and Reproductive Health (JFRH), Guttmacher Institute, International Federation of
Gynecology and Obstetrics (FIGO). A final effort was made to ensure capture of any relevant articles by running
two simplified searches in PubMed, results were duplicates with articles that had already been identified, and
the searches were:
[“task shifting” AND Nigeria AND (“Magnesium sulfate” OR “magnesium sulphate”)]
and
[(“magnesium sulfate” OR “magnesium sulphate”) AND Nigeria].
Articles were excluded prior to phase I review if they were duplicate citations, if they pertained to non-human
subjects, or if it was evident from the title that the article was not related to Nigeria (e.g. specifically identified
the location of the study as somewhere other than Nigeria).
Titles and abstracts for the articles were imported into an excel spreadsheet adapted from “Excel Workbook for
2 Screeners” by Helena VonVille, licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0
Unported License, available online at http://libguides.sph. uth.tmc.edu /excel_SR_workbook.
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PHASE I: EXCLUSION CRITERIA
During Phase I of the systematic review two independent reviewers KK and IC conducted title and abstract
screening to determine if the abstracts should be included or excluded in the next phase of the review. Abstracts
were excluded if they were:
1) Not about Nigeria,
2) Not related to pregnancy; (for example: abstracts about male subjects and abstracts that discussed
hypertension but not in pregnancy were excluded),
3) Not related to PE/E or associated risk factors, symptoms, or complications.
The two screeners then reconciled their reviews and in cases where it was unclear from the abstract if an article
would provide relevant information, the screeners consulted the full text of the article.

PHASE II: INCLUSION AND EXCLUSION
In the second phase, the two reviewers read the full texts of the remaining articles to determine their relevance
and eliminated any papers that were not related to PE/E, did not focused enough on Nigeria or did not provide
any substantive data or observations specific to Nigeria, and any papers for which a full text could not be
acquired.

PHASE III: CATEGORIZATION
Finally, the remaining articles were sorted into five types of papers—based on the main topic of each—that were
found during the systematic review.
1)
2)
3)
4)
5)

Intervention: papers that explore questions related to prevention and treatment of PE/E
Potential risk factors for pre-eclampsia and eclampsia
Other health outcomes associated with pre-eclampsia and eclampsia
Descriptive papers: including program descriptions/summaries and literature reviews
Reviews of hospital case files summarizing maternal mortality rates, causes of maternal mortality and
the proportion of maternal mortality attributable to PE/E (and other hypertensive disorders in
pregnancy).

The goal was to identify articles that presented evidence on interventions that addressed the diagnosis,
treatment, or prevention of pre-eclampsia or eclampsia.
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Results
After removing duplicate citations and those that were obviously unrelated to this review, the initial database
searches identified 520 abstracts which were included in Phase I review. The two reviewers removed 338 articles
that were deemed to not fulfill the inclusion requirements for Phase I. During Phase II, 37 articles were removed
because they did not provide enough, relevant information specific to Nigeria or a full text document could not
be located (details in Appendix II). A total of 145 articles were included in the systematic review.

FIGURE 2 Flow diagram of systematic review methods and results
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SUMMARY OF TOPICS FROM THE LITERATURE
Strategies for prevention and treatment of PE/E
Nineteen studies relating to strategies for the prevention and/or treatment of PE/E were identified in this
systematic review. Key data was extracted from these papers and compiled in a summary table (see Appendix
III). These articles look at possible strategies for reducing mortality due to pre-eclampsia and eclampsia in
Nigeria.
There were six major topics that emerged from these nineteen papers looking at best practices for preventing
and treating PE/E including: confirming MgSO4 is safe and effective, testing different dosing mechanisms,
determining different methods for delivering patients with PE/E, improving case monitoring, creating and
incorporating policy and management guidelines, and re-training of providers/task-shifting to lower cadres.
MgSO4 is safe and effective
Two papers confirm that magnesium sulphate is a safe and effective treatment for eclampsia and is a better
option than other anticonvulsants like diazepam. Altman et al. performed a randomized placebo-controlled trial
(known as the Magpie Trial) that showed that in 33 countries (including Nigeria) which demonstrated that MgSO4
is safer and more effective for controlling fits in eclamptic women than diazepam (Altman et al., 2002). The
Magpie Trial was the first large, multi-country, randomized trial to generate evidence on the safety and efficacy
of MgSO4 in women with eclampsia; this study lead to the determination that MgSO 4 is the drug of choice and
should be used over other anticonvulsants to control eclamptic fits.
The second paper, Ugwu et al. involved a before-and-after comparison of health outcomes based on
retrospective case review from hospital records (Ugwu et al., 2011). During the three year study period, the
University of Nigeria Teaching Hospital, Enugu, saw 77 cases of severe PE; 47 of whom were treated with
diazepam and 30 of whom received MgSO4. Only one woman experienced recurrent seizures, and she had been
treated with diazepam. During the study, no maternal deaths occurred due to severe PE, however, women in the
diazepam group were more likely to experience prolonged hospital stay.
MgSO4 dosage
There are currently two predominant regimens for administering MgSO 4 to women with severe PE, impending
eclampsia, or eclampsia: the Pritchard regimen and Zuspan regimen. The Pritchard regimen has been
considered the ‘gold standard’ treatment method in low resource settings since 1925, but there is no evidence
to show that this is best and most efficient mode of treating convulsions associated with PE/E. The Zuspan
regimen requires more medical skills and equipment (involves setting up an infusion pump).
Four papers identified in this review looked at the question of dosage and tested alternate regimens. One was a
descriptive comparative study conducted at the Federal Medical Centre in Katsina where women presenting with
severe PE during the two study periods received a different dosage of MgSO 4 (Okusanya et al., 2012). The 54
women who were enrolled during the first study phase received a 10g dose of MgSO4 and 49 women in the
second study phase received the 14g associated with the standard Pritchard regimen. Overall, the health
outcomes from both groups were comparable: similar rates of vaginal delivery, onset of convulsion/recurrent
convulsion, maternal death, and neonatal Apgar score were not significantly different between the two groups.
Ekele and Ahmed conducted an experimental pilot in 2002-2003 that used the same loading dose of MgSO4 but
limited the maintenance doses for 12 hours following the loading dose (compared to the 24 hours stipulated in
the Pritchard regimen)(Ekele & Ahmed, 2004). Thirty-three women participated in this study and the results seem
to indicate that the primary outcome of interest—rate of recurrent convulsion—in these women (6.0%) is
comparable to the rate documented in the large MgSO4 Collaborative Eclampsia Trial (Magpie Trial) that followed
the standard, Pritchard regimen (4.7%).
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The other two papers looking at the dosage question were randomized control trials. Chama and Geidam
randomized 112 patients into standard treatment group (Pritchard) and a shortened postpartum course which
involved administering only two IM injections four hours apart (Chama & Geidam, 2013). The findings indicated
that the shortened postpartum course was as effective as the Pritchard regimen to manage eclampsia. While
Chama and Geidam shortened the postpartum maintenance in their study, Abdul et al. instead modified the
antepartum loading and maintenance doses (Abdul, et al., 2013). During their study, Abdul et al. randomized 72
patients into standard dose (n=33) and low dose (n=39) groups. The low dose regimen reduced the amount of
MgSO4 required in the standard, Pritchard. The women in the low dose group received a 9g loading dose (4g IV,
2.5g in each buttock) followed by 2.5g in alternate buttocks every four hours. Though the sample size was small,
this study found no significantly different rates in maternal or perinatal mortality or in Cesarean section (CS) rate.
Delivery methods for PE/E cases
The only definitive treatment for eclampsia is to end the pregnancy by delivering the baby and placenta. It is,
therefore, understandable that PE/E leads to increased rates of cesarean section (CS) deliveries in populations
with high rates of PE/E. Afolayan and Tukur explore two different aspects of labor and delivery in order to
determine which methods have the best outcomes for mother and baby.
Afolayan et al. conducted a retrospective case review that compared complication rates between using general
anesthesia or spinal anesthesia during caesarean section deliveries among eclamptic women (Afolayan et al.,
2014). The study showed that maternal and perinatal survival among eclamptics are better among those who
received spinal anesthesia during their caesarean section procedure.
Tukur examines the outcomes for eclamptic mothers and their babies who underwent caesarean section versus
those who had labor induced using misoprostol (Tukur et al., 2007). Their study found that although both
methods were effective, misoprostol requires more time to fully induce labor and should therefore only be used
when prompt and safe caesarean section is not available.
Improved case management and monitoring
Case management and monitoring can be modified and improved and at different stages throughout the
development of the condition; three papers looked at strategies to improve case management for women with
PE/E. One looks at a strategy to manage early PE, one incorporates a tool for streamlining monitoring and
treatment, and the third tests the role of serum magnesium levels in eclamptic patients as a way to prevent and
detect MgSO4 toxicity.
In a prospective, case-control study conducted in Enugu, 749 consecutive cases of pre-eclampsia admitted to
the University Teaching Hospital were recruited; 175 cases were deemed to be ‘early onset’ (before 30 weeks
gestation) and made up the study group and 574 served as controls (Onah & Iloabachie, 2002). All participants
were tested for blood count, serum electrolytes, urea and creatinine, liver function, clotting profile, urinalysis and
ultrasonography. When necessary, they were treated with antihypertensives (alpha-methyldopa used antepartum
and hydralazine used in the event of a hypertensive crisis) and diazepam (to control convulsions). The women in
the early onset group were conservatively managed using antihypertensives and diazepam until maternal and/or
fetal risks meant that continued conservative management was considered dangerous; 80% gained more than
two weeks gestation using this method of management. Women in the late onset group were delivered promptly,
especially if the woman was beyond 34 weeks gestation. While conservative management may improve fetal
outcomes, this study saw an increase in maternal morbidity and mortality among the study group participants
which was likely due in part to facility delays and the unavailability of MgSO4. The authors suggest that
conservative management has potential to improve fetal outcomes but in order to improve maternal outcomes,
institutional delays need to be reduced and MgSO4 needs to be available.
Ameh et al. developed a monitoring chart that simplified the paperwork and compiled all relevant details onto
one sheet (Ameh et al., 2012). The improved chart, the LIVKAN chart allows for the patient’s blood pressure to
be tracked over time as well as the number and timing of convulsions, patient’s level of consciousness,
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proteinuria, respiratory rate, deep tendon reflex. Furthermore, any drugs needed to manage high BP (hydralazine,
nifedipine, labetolol), eclamptic fits (MgSO4), or MgSO4 toxicity (calcium gluconate) are also recorded in the chart.
Missing from the chart, however, is methyldopa, another antihypertensive that is usually affordable and
available. In order to assess the effectiveness and acceptability of the LIVKAN chart, Ameh et al. trained 118
skilled birth attendants on its use and followed up with questionnaires. The study found that 98% of the
participants thought that the LIVKAN chart was an improvement over the existing monitoring system and would
be useful at their level and at lower levels to improve care and documentation of referral. The challenges cited
include: low availability of blank charts and high workload due to paperwork. Overall, the chart appears to
improve monitoring of PE/E by combining monitoring and treatment guidelines and allowing for 24 hour
surveillance of a patient experiencing PE/E in one single page.
Finally, whenever a patient is treated with MgSO4, she must be monitored for indications of toxicity from MgSO4.
Ekele and Badung quesiton the role of serum magnesium levels in patients receiving MgSO 4 as an indicator of
possible toxicity. During their prospective study, they recruited 19 patients who presented with eclampstic
convulsions and were treated using MgSO4; blood samples were taken from patients prior to administration of
MgSO4 to assess whether there was a significant change in serum magnesium levels (Ekele & Badung, 2005).
This small study found that serum magnesium levels in eclamptic patients do not change drastically and they
remain within therapeutic levels and conclude, therefore, that serum magnesium level estimation is not
necessary in patients with eclampsia being treated with MgSO4.
Policy and management guidelines
Establishing policies and institutionalizing guidelines support clinical efforts to manage cases of PE/E. Three
papers included in this review examined the impact of guidelines and policies on maternal mortality related to
PE/E. Nkwocha et al. looked at the impact of a global call to action—the Safe Motherhood Initiative—that was
adopted in Nigeria in 1990 and called for a reduction in maternal mortality by 50% by 2000. Igwegbe et al.
assessed the impact of a facility-specific policy and Ezugwu et al. looked at guidelines within a specific facility to
assess the effect on maternal mortality due to PE/E.
Nigeria launched the Safe Motherhood Programme in 1990 with the express purpose of reducing maternal
mortality by half in ten years (Nkwocha et al., 2006). Nkwocha et al. reviewed hospital cases from eight years
before (1981-1989) and eight years after (1990-1998) the introduction of this initiative in Nigeria. The study
found that while the overall MMR decreased by 8% between the two study periods, maternal deaths due to PE/E
increased after 1990. Prior to 1990, PE caused 4.4% and eclampsia caused 10.5% of maternal deaths, after
1990 these rates increased to 13.9% and 17.9%, respectively. These findings indicate that PE/E represents a
priority area that requires more focus in order to reduce the associated maternal death.
In 2005, the Nnamdi Azikiwe University Teaching Hospital (NAUTH) introduced a “Service Compact” (SERVICOM)
contract in response to a federal proclamation to provide all Nigerians with “basic services to which each citizen
is entitled in a timely, fair, honest, effective and transparent manner” (Igwegbe, Eleje, Ugboaja, & Ofiaeli, 2012).
The SERVICOM charter at NAUTH included mandates including: elimination of fee-for-service for all emergency
services (which included emergency obstetric services), prompt and appropriate treatment, and monitoring of
services and record keeping. Igwegbe et al. reviewed hospital records from before and after the introduction of
the SERVICOM charter at NAUTH to determine if the policy had any effect on maternal mortality. Overall, the
maternal mortality rate at the facility from 2004-2010 was 1,098 per 100,000 live births and eclampsia
contrubuted 25% of the maternal deaths. Before SERVICOM, the 2004 maternal moratily rate was 1,567 per
100,000 live births compared to 691 per 100,000 in 2010. Igwegbe et al. showed that introducing a policy like
the SERVICOM charter can improve quality of care, timeliness of treatment and maternal health outcomes which
may have implications for maternal outcomes related to PE/E.
In 2008, the Enugu State University Teaching Hospital adopted evidence-based guidelines aimed at reducing
maternal mortality (Ezugwu et al. 2014). This study reviewed hospital records from three years before the
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institutionalization of the guidelines and three years after in order to compare the maternal outcomes at the
facility and to determine if the guidelines had an impact. The guidelines were identified through PubMed and
Google scholar; they were adapted to the local context and included guidelines on the management of severe
PE using the Pritchard regimen. The three years after the introduction of the guidelines at the facility showed a
43.5% reduction in MMR when compared with the three years prior to the guidelines. The case fatality rate fell
by 80% (from 15.8% to 2.7%) after introducing the guidelines and training providers on them. This study by
Ezugwu et al indicates that institutionalization and training on guidelines related to management of PE/E can
reduce maternal mortality.
Re-training and task-shifting
The final major theme that emerged from the literature on strategies for improving prevention and management
of PE/E is focused on increasing access through provider knowledge and skills. Five studies were on training, retraining and task-shifting as a way of improving access and quality of care for patients with severe PE/E.
In a multi-state study, Okonofua et al. conducted a before-and-after trial in six health facilities that sought to test
the impact of training various professionals (Ob/Gyns, doctors in training, nurses, midwives and others) on the
proper treatment of PE/E cases using the Pritchard regimen, antihypertensives, and monitoring the patient
(Okonofua et al., 2013). To establish a baseline and identify gaps in knowledge, the researchers reviewed
hospital records from January to May 2008 and conducted in-depth interviews (IDIs) with providers to inform
development of the training materials. The endline data was prospectively collected for one year after the
intervention. Incidence of eclampsia was comparable at baseline and endline but the case fatality rate
decreased from 15.1% at baseline to 3.2% at endline. This study found that the trainings successfully built the
capacity of the healthcare providers to safely use MgSO4 and effectively reduced deaths due to eclampsia.
Ishaku et al. conducted a case-control study where they assessed whether lower-cadre health workers could
detect severe PE/E and safely administer the loading dose of MgSO 4. In their study, ten primary health care
facilities in Kano state were included, 5 made up the experimental arm and 5 were controls (Ishaku et al., 2013).
At the experimental facilities, health workers received training on how to recognize cases of severe PE/E and
learned how to administer the loading dose of MgSO4 (10g IM) and refer women for follow up care. In addition
to recognizing and initiating treatment for severe PE/E, the PHC providers also received instruction for detecting
MgSO4 toxicity and treating it with calcium gluconate. The PHC providers at the control facilities did not give
MgSO4 or diazepam. During this study, a higher proportion of women defaulted from experimental facilities than
in the control facilities; this was potentially due to the immediate, yet temporary, effect of MgSO4. This study
demonstrated that PHC providers can safely and effectively administer the loading dose of MgSO 4 in patients
with severe PE/E, however referral mechanisms need to be strengthened to reduce the 75% default rate seen
in this study.
The remaining three papers are reporting on data collected during the same or complementary studies that were
implemented in ten facilities in Kano state from February 2008 to December/January 2009 (Okereke, Ahonsi,
Tukur, Ishaku, & Oginni, 2012; Tukur et al., 2011; Tukur et al., 2013).
The intervention trained twenty-five individuals on evidence-based management of hypertensive disorders of
pregnancy and use of MgSO4 (five hospital board officials and one midwife and one doctor from each of the ten
facilities). These 25 people were considered “Master Trainers” and together trained another 160 health workers.
These papers report a baseline case fatality rate of 20.9% compared to 2.3% after the intervention.
This evidence-based intervention was successful because it engaged with stakeholders and it is replicable (Tukur
et al., 2011). Training providers on protocols for the treatment of severe PE/E using MgSO 4 was determined to
be an effective strategy to reduce case fatality due to eclampsia without incurring any significant increase in cost
(Okereke et al., 2012). This effective, low-cost, replicable intervention has a positive effect on maternal and fetal
mortality and morbidity and should be implemented on a wider scale (Tukur et al., 2013).
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Demonstrated and Potential Risk Factors
While the biological mechanism for developing eclampsia remains unknown, many studies look at various
attributes or conditions in an effort to identify risk factors for developing PE/E. Among the potential risk factors
explored in the literature are: maternal ethnicity, adolescent mothers, sickle cell anemia, parity, and history of
hypertension or prior pre-eclampsia. Thirty-six papers looked at demonstrated or potential risk factors for PE/E
that had the potential to improve early detection (Appendix IV).
Previously demonstrated risk factors for PE/E that appear in the literature from Nigeria and include: low parity,
young age, multiple gestation, history of chronic high blood pressure, previous pre-eclampsia, and not registering
or booking at a health facility for ANC (Adokiye & Isreal, 2015; Anorlu et al., 2005; Olusanya, 2011; Osungbade
et al., 2008; Owolabi et al., 2008). Three papers looked specifically at young age and determined that
adolescence is a risk factor for PE/E, though the papers did not look at explanations for this fact (Adeyinka et
al., 2010; Airede & Ekele, 2003; E. I. Nwobodo & Panti, 2012).
While rise in blood pressure is known to be associated with PE/E, one paper investigated whether or not a relative
rise versus absolute rise in BP would be better to predict maternal and fetal outcome. After following a cohort of
478 women and tracking blood pressure levels throughout the study period, Onah concluded that fetomaternal
outcomes were not significantly affected by relative rise in diastolic BP and concluded that absolute BP is a
better predictor of fetomaternal outcome (Onah, 2002).
Twenty-one other papers looked at potential risk factors relating to biomarkers in pregnancy. Each looked at a
specific set of biological measures to determine if there were any observable trends or associations between the
biomarker and the development of PE/E. These included: various antioxidant vitamins, magnesium or
magnesium serum levels, trace element levels, lysosomal enzymes or enzymic antioxidants, among others
(Appendix IV). Based on these studies, elevated levels of haptoglobin, malondialdehyde, phenylalanine
concentration, blood lead and homocysteine levels were observed in pre-eclamptic women and may contribute
to the development of PE/E. Low serum concentrations in zinc, copper, manganese and magnesium, and low
plasma calcium, vitamin C and E levels could indicate PE/E or risk of PE/E in pregnant women.
The remaining papers tested the effect of maternal ethnicity, seasonality, past abortion and change in paternity,
socioeconomic status and polygamy on a woman’s risk of developing PE/E (Abubakar et al., 2009; Attahir, et al.,
2010; Chigbu et al., 2009; Familoni et al., 2008; Okafor & Ezegwui, 2010; Olayemi et al., 2010; Olayemi, et al.,
2010). All of these studies were specific and small but their findings indicate the potential need for further
research into risk factors for PE/E. Abubakar et al. found that the Fulani ethnic group was more likely to progress
from PE to eclampsia when compared to Hausa and Kanuri women. Attahir et al. learned that seclusion and
polygamy did not have an effect on rates of PE. Okafor reported from a retrospective review of hospital records
that women with PE were more likely to undergo CS during the rainy season.
While these findings are certainly interesting, they are looking only at a relatively small number of women and
are not sufficient to consider these aspects as risk factors for PE/E.

Other Health Outcomes associated with PE/E
In addition to the common, known health outcomes of PE/E (edema, headache, seizure, and death), other health
outcomes are associated with PE/E. Twenty-three papers identified during this review reveal other health
outcomes that can affect mother and/or fetus including: fetal malnutrition, poor Apgar scores increased chance
of cesarean section (CS), cardiac complications and persistent hypertension (Appendix V).
Among the less-common outcomes associated with PE/E were: orofacial injuries, loss of vision, and paralysis.
The orofacial injuries are not caused by PE/E, however, but are the result of objects being forced into the mouths
of eclamptic women in a misguided effort to mitigate consequences of the seizures (Adeyemo & Rabiu, 2012;
Ndukwe et al., 2004). While change in vision is a more common consequence of PE/E, total loss of vision occurs
less often but one such case is reported in the literature (Waziri-Erameh et al., 2003). The literature also revealed
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a rare case of a 26-year old woman who was brought into a facility with postpartum eclampsia and was left
quadriplegic, a rare yet real consequence of her eclampsia (Okafor & Efetie, 2006).
Since MgSO4 only allows for the temporary management of eclampsia, many women suffering from the condition
must be delivered pre-term; this leads to an increase in the number of caesarean section (CS) deliveries that are
performed which, in turn, increases the woman’s chance of suffering a morbidity or mortality from the procedure
(Adeoye et al., 2013; Oladapo et al., 2004; Okafor & Ezegwui, 2010; Okafor, 2009; Ozumba & Anya, 2002).
Further to the increase in caesarean sections and associated morbidities and mortality for the mother are the
increased negative health outcomes for the fetus/baby. With an increase in pre-term deliveries, there is a
heightened burden of low birthweight babies (Olusanya & Solanke, 2012a, 2012b; Onyearugha & Ugboma,
2012a).
Another health outcome of PE/E is HELLP syndrome, a dangerous condition that complicates eclampsia with
hemolysis, elevated liver enzymes, and low platelets. HELLP syndrome causes the internal organs to shut down,
and left untreated, the mother’s health, as well as the fetus’ health, will quickly deteriorate (Makinde, 2009).
It is important to remember that PE/E has negative health effects on the fetus/newborn as well as the mother.
Eight papers reviewed discuss the fetal/neonatal outcomes associated with PE/E including fetal malnutrition,
low birth weight (LBW), preterm birth (PTB), low Apgar score and fetal death. For example, Onyearugha et al.
conducted a study based on the hospital records for 48 babies delivered to eclamptic mothers in Abia state. The
records showed that 13 babies were LBW <1500g, and 29 (60%) were stillborn and four were severely
asphyxiated; the authors suggest that these poor Apgar scores could be impacted by ‘asphyxiogenic effect’ in
utero during eclamptic convulsions (Onyearugha & Ugboma, 2012b).

Program descriptions and literature reviews
Thirteen of the papers reviewed were categorized as being descriptive articles and included: project summaries
(three), literature reviews (five), purely cross-sectional studies (three), and editorial or correspondence articles
(two). Some of the topics covered in these descriptive papers were: verbal autopsy to determine cause of
pregnancy-related death in a population, assessment of nurse-midwife educators on causes of maternal
mortality, determine whether brief summaries of these descriptive papers relating to PE/E in Nigeria can be
found in Appendix VI.

Summaries of hospital case notes and records for PE/E
A majority of the papers collected for this review are a specific kind of a descriptive paper; they are summaries
of hospital reports of eclampsia or, more broadly, maternal mortality. The 54 papers that fall into this category
report maternal mortality ratios, the attributable proportion of MMR to PE/E, incidence of PE/E, and case fatality
rate at a specific facility during a specific time period and do not provide any analysis or interpretation. The
facilities are from across the country, with a greater concentration in the South West and South East (Figure 3).
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FIGURE 3 Map of facilities where records were reviewed

The MMRs reported in these papers cover specific periods of time over the last three decades; Olatunji et al.
reviewed data from a facility in Sagamu in Ogun state that included cases from 1988-1997; their review found
92 maternal deaths out of 5,423 deliveries making the MMR at that facility at that time, 1,696 per 100,000
deliveries. The lowest MMRs reported include 463 per 100,000 live births (44 maternal deaths) at the Federal
Medical Centre in Kogi state from 2005-2009 (Alabi et al., 2012) and 454 per 100,000 from Edo state in 19962000 (Onakewhor & Gharoro, 2008). The highest MMRs reported among these summary papers include one
from a rural referral hospital, Baptist Medical Centre, in Delta state. The cases reviewed were from 1994—2003
and revealed 115 maternal deaths out of 5,153 deliveries making the MMR= 2,232 per 100,000 live births
(Igberase & Ebeigbe, 2007). Another extraordinarily high MMR of 2,849 per 100,000 deliveries comes from a
tertiary facility that experienced 112 maternal deaths out of 3,931 deliveries from 2003-2007 (Kullima et al.,
2009). The highest observed MMR comes from Olabisi Onabanjo University Teaching Hospital in Sagamu in Ogun
state from 2000-2005 where 75 maternal deaths and 2,509 live births were recorded making the MMR=
2.989.2 per 100,000 live births (Oladapo et al., 2006).
In addition to reporting on MMRs at facilities, the authors also reported on the proportion of MMR that is
attributable to PE/E. These proportions also varied, every paper that reported the proportion of maternal deaths
caused by hypertensive disorders in pregnancy, PE/E, severe PE/E, eclampsia, was over ten percent (Figure 4).
The proportions ranged from 12.4% of 97 maternal deaths (Nwagha et al., 2010) to 42.2% of 277 maternal
deaths (Nwobodo & Ahmed, 2011).
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FIGURE 4 Attributable proportion of maternal death due to PE/E as reported in the literature

Two papers, examined ‘maternal near miss’ cases to get a larger sample size and a better idea of the causes of
severe maternal outcomes even in cases where the woman survived. These also found that a large proportion
of cases were due to PE/E. Adeoye et al. saw that hypertensive disorders in pregnancy (which they defined as
severe PE/E) caused 37.3% of near miss cases at the maternity units of Obafemi Awolowo University Teaching
Hospitals Complex in Ile-Ife from July 2006-June 2007. In a recent cross-sectional study of 91,724 live births,
Oladapo et al. found 2,440 severe maternal outcomes (1,451 maternal near-miss and 998 maternal deaths).
Of these 2,440 cases, hypertensive disorders (chronic hypertension and PE/E) were the most common cause
and contributed 24% of the SMOs and eclampsia was found to be the most frequent complication and resulted
in 20% of the maternal deaths (Oladapo et al., 2015).
The papers already discussed in this section were looking at all causes of maternal mortality/maternal near
misses and reported on overall MMR and attributable proportion of maternal death to PE/E among other health
conditions; the remaining summaries of hospital records look at reports from cases of PE/E specifically and
report on prevalence/incidence and case fatality rates. Incidence/prevalence of PE/E ranged from very low:
0.42% (Onwuhafua et al., 2001) and 0.75% (Ikechebelu & Okoli, 2002) to very high: 9.42% (Tukur, Umar, &
Rabi’u, 2007). For obstetric complications, the United Nations has set the maximum case fatality rate at 1% of
cases; every paper reporting CFR in this literature review found CFR over 1%, most were over 10% and one study
found CFR as high as 42.22% (out of 45 cases) (Onwuhafua et al., 2001).
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Discussion
GAPS IN PREVENTION OF PE/E
Globally, aspirin and calcium are thought to have a protective effect for women at risk of developing PE/E. This
potential prophylactic effect is only very briefly mentioned in a few papers and none of the studies test the effect
of these two supplements on the incidence of PE/E. The effectiveness and impact of prophylactic aspirin and
calcium are unknown in the Nigerian context.

GAPS IN DETECTION OF PE/E
Terminology and clinical definitions
Throughout the 145 full text articles reviewed in this paper, there is no consistency in terminology used or in
clinical definitions for those terms; each paper provides their own definitions with some overlapping criteria.
Among the various terms used throughout the literature were: hypertensive disorders of pregnancy, mild
pregnancy-induced hypertension (PIH), PIH, severe PIH, chronic hypertension with superimposed pre-eclampsia,
pre-eclamptic toxaemia (PET), severe PET, toxemia of pregnancy, the toxaemia syndrome, mild pre-eclampsia,
pre-eclampsia, severe pre-eclampsia, imminent eclampsia, impending eclampsia and eclampsia.
Currently, with the plethora of accepted terms used to refer to varying degrees of PE/E severity, studies are
forced to define the clinical parameters for each condition. While some of the definitions contain similarities or
overlapping criteria, there are often specific differences between them. Below are a few examples of definitions
from the literature
Mild pre-eclampsia




“a blood pressure of 140/90 mmHg on two occasions 6 h or more apart, or a rise of 30 mmHg systolic
or 15 mmHg diastolic from mid-trimester values; proteinuria above (+) on two consecutive urine
specimens and significant non- dependent oedema” (Okafor & Okezie, 2005).
“Pregnancy-induced systole hypertension of 140 to <160 mmHg (or diastole hypertension of 90 to <110
mmHg) with proteinuria of 2+ (100 mg/dL)” (Osinubi, Ajayi, & Adegbola, 2009)

Pre-eclampsia









15

“Preeclampsia, a multisystem disorder unique to human pregnancy is defined as the association of
pregnancy induced hypertension with proteinuria of greater than or equal to 300mg/24h after 20 weeks
of gestation” (Okafor & Ezegwui, 2010)
“Hypertension after the 20th week of gestation, the diastolic blood pressure >110 mmHg on admission,
proteinuria >30mg/dl in random urine specimen or > 300mg in a 24hr urine specimen” (Makinde,
2011)
“Hypertension (?140/ 90mmHg on two occasions 4h apart) and proteinuria (>0.3g/dl) in the second
half of pregnancy” (Adeyinka et al., 2010)
“Hypertension (systolic pressure = 169 ± 26.0 mmHg, diastolic pressure = 102 ± 11.0 mmHg),
significant proteinuria (368 ± 39 mg/24 h), severe headache, abdominal pain and vomiting.” (Akiibinu,
Kolawole, Ekun, & Akiibinu, 2013)
“Significant proteinuria (>100 mg/day) and high blood pressure (>130/90 mm Hg) irrespective of
weight of the patients or the presence of edema. The blood pressure must have manifested on at least
two occasions 6 hours or more apart.” (Arinola, Arowojolu, Bamgboye, Akinwale, & Adeniyi, 2006)





”Blood pressure of >140/90 mmHg on at least two occasions measured at least 6 h apart or a diastolic
blood pressure of 110 mmHg at any time or an increase of 30 mmHg and 15 mmHg in the systolic and
diastolic blood pressures, respectively from the booking values or a mean arterial pressure of greater
than 105 mmHg” with “two midstream urine specimens more than 4 h apart with 2+ protein on dipstix
testing or 1+ protein with measured specific gravity of 41.03 and < 8” (Chigbu et al., 2009)
“Cerebral or visual disturbances, epigastric pain, pulmonary edema or cyanosis, a systolic blood
pressure >140 mm Hg or a diastolic blood pressure >90 mm Hg and proteinuria.”(Glew et al., 2004)

Severe pre-eclampsia





“The blood pressure is persistently above 160/110 mmHg and proteinuria above 5 g/24 h (+++) and
symptoms of headache, blurring of vision, epigastric pain and oliguria.” (UV Okafor & Okezie, 2005).
“New hypertension with blood pressure of 160 mmHg systolic or diastolic blood pressure of 110 mmHg,
or greater, arising after 20 weeks of gestation in a woman who was normotensive before 20 weeks
gestation, associated with proteinuria […] 2+ or more protein on urine dipstick.” (Guerrier, Oluyide,
Keramarou, & Grais, 2013)
“If any two of the following signs were present: (1) systolic blood pressure >160 mmHg or diastolic blood
pressure >110 mmHg; (2) proteinuria (>3+ on dipstick [500 mg/dL]); (3) facial oedema.” (Osinubi et
al., 2009)

Eclampsia







“…maternities that presented with fitting or fitted while on admission, had blood pressure equal to or
greater than 140/90 mm Hg, at least 2 +proteinuria with or without edema, and had no past history of
epilepsy.” (B. Ekele, Bello, & Adamu, 2007)
“hypertension after the 20th week of gestation, the diastolic blood pressure >110 mmHg on admission,
proteinuria >30mg/dl in random urine specimen or > 300mg in a 24hr urine specimen […] plus
headache, blurring of vision and upper abdominal pain […] and seizures” (O. N. Makinde, 2011)
“associated with convulsions, oliguria (4400ml/24h), increased tendon reflex, pain in the right
hypochondriac region.” (Adeyinka et al., 2010)
“Occurrence of seizure and/or altered level of consciousness not caused by epilepsy or other convulsive
disorders, with signs of severe preeclampsia.” (Guerrier et al., 2013)

Creating specific and clear clinical definitions for these conditions is essential to ensuring that providers around
the globe are able to appropriately diagnose and manage the symptoms related to PE/E. Generally speaking,
“toxemia” is an outdated term that is not frequently used today to classify types of hypertensive disorders of
pregnancy. Given the wide range of definitions related to hypertensive disorders in pregnancy, it is necessary to
reduce the number of terms and simplify the definitions to move beyond the implication that interventions vary
significantly between each classification, when in fact, the monitoring and management methods are not so
different between mild PE and PE or severe PE and eclampsia.

ANC attendance, content, and quality
One message that comes through clearly in the literature is that “booked” patients are less likely to develop
PE/E when compared to “unbooked” women. This trend is not surprising as women who attend ANC will be more
likely to be screened for PE/E and receive preventative care and careful monitoring before the condition worsens.
Women who do not attend ANC are unlikely to be aware of any problem until eclamptic seizures begin. What is
not always clear from the literature are the details about which services the women attending ANC are receiving
and whether or not they know what danger signs to look for in pregnancy. Attending ANC and receiving all
essential ANC services is required for early detection of PE/E and to prevent the women with early signs of
preeclampsia from worsening.
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GAPS IN TREATMENT OF PE/E
The literature very clearly supports the use of MgSO4 to manage eclamptic convulsions; MgSO4 is not the only
weapon that we have against PE/E. If indicators of PE/E are detected early in pregnancy, these symptoms can
be managed using antihypertensive drugs before the condition escalates.

Antihypertensives
There is nothing in the literature that specifically reports on the effectiveness and safety of antihypertensives for
pregnant women with high blood pressure; a few mention that as part of their treatment procedure, women were
receiving antihypertensives to manage their high BP. Using antihypertensive drugs (labetalol, nifedipine,
methyldopa, hydralazine) to manage high blood pressure in pregnant women is an important strategy to reduce
the number of PE cases that escalate to eclampsia.

Use of MgSO4
Despite the abundance of evidence demonstrating the safety and effectiveness of MgSO4, its use has remained
low, especially in developing countries where it, incidentally, is most needed. Low availability of MgSO4, lack of
guidelines on its use (or unawareness of these guidelines), misinformation regarding who can administer the
drug, poor knowledge of health workers on its use, fear of toxicity, little incentive for pharmaceutical companies
to commercialize the drug (no profit to be made), ready availability of pre-packaged forms of less effective drugs
(like diazepam), and lack of support for policy change all contribute to the underutilization of this safe and
effective life-saving drug. Even if providers are trained to use MgSO4 and know how and when to use it,
sometimes providers choose to use diazepam instead because they are more familiar with it since it was the
recommended drug for PE/E in Nigeria for decades before MgSO4 was introduced (Ekele, 2009).
In addition to the relatively low use of MgSO4, there are no studies that demonstrate the lowest effective dose
to manage PE/E. As described earlier in this paper, some researchers have started questioning and testing the
dosage with preliminary results indicating that a reduced dose—either in amount delivered or timing of doses—
can be as effective as the generally-accepted Pritchard regimen.
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Conclusion
Throughout the development of a pregnancy, there are many opportunities when PE/E can be prevented,
detected and managed; based on the literature, certain gaps exist along this continuum of care. In order to have
the most impact, we recommend a multi-level set of interventions that increase community awareness of
symptoms of PE/E and ANC health seeking behavior, improve and expand provider skills and knowledge at
multiple levels (including PHC) for detecting and treating high BP in pregnancy and PE/E throughout the
developmental stages of pregnancy. Figure 5 visualizes the cycle of pregnancy and specific strategies that are
currently thought to be the best practices to reduce maternal mortality related to PE/E; the blue stars correspond
to opportunities that hold the most potential for significant reduction of incidence of eclampsia and subsequent
death.

FIGURE 5 Opportunities and strategies for preventing, detecting and treating PE/E

*orange text indicates adverse outcomes for which providers should monitor and be prepared to manage
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RECOMMENDATIONS
Develop common language and clear streamlined policies



Develop simple terminology and associated definitions for global use.
Continued advocacy to hospital administrators and relevant policymakers to ensure that protocols are
followed over time and that the necessary drugs and equipment are procured.

Clarify and define management strategies and dosage




Determine the minimum effective dose for MgSO4.
Create and distribute clear and concise guidelines and protocols for treating PE/E with
antihypertensives and MgSO4.
Assess the effectiveness and need of aspirin and/or calcium prophylaxis in Nigeria.

Increase access to quality services



There should be training and re-training of healthcare providers on recognizing PE/E, managing high BP
with antihypertensives, when and how to administer MgSO4, and how to monitor for and treat toxicity.
Task-shifting can increase the workforce capable of providing life-saving services; PHC providers can
and should be able to detect and provide initial treatment (antihypertensives and MgSO 4 loading dose)
for PE/E and monitor for toxicity.

Engage Community
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Increase community awareness of and access to antenatal care.
Educate community members on the signs and symptoms of PE/E and when and where to seek
treatment.
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Study Design

Location,
Timeframe, and
Sample size
Labour Unit,
Obstetrics and
Gynecology Federal
Medical Centre,
Azare, north-eastern
Nigeria

Randomized
Controlled
Trial

January to August
2008

72 patients
recruited, 39
randomized into lowdose group, 33 were
in standard regimen
group
University of Benin
Teaching Hospital,
Benin City, Nigeria
Retrospective
case review

January 1, 2011—
December 31, 2012

99 cases of
eclampsia

Prevalence
/
Incidence/
CFR

Main findings/ limitations
Brief summary of methods/intervention

Conclusions/
Recommendations



Prevalence
rate of
eclampsia
= 4.2%

CFR= 5.5%

Standard dose: 14g loading dose of MgSO4
(4g IV, 10g IM) followed by IM maintenance
dose of 5g every four hours



Low dose: 9g loading dose of Mg SO4 (4g IV,
5g IM) followed by IM 2.5g every four hours









Incidence
of
eclampsia:
170 in
10,000 =
1.7%


Patients’ case notes were reviewed; clinical
and demographic data was extracted and
analyzed.





Primigravidas: 57% of cases.
44% intrapartum, 26% antepartum, and 15% postpartum
eclampsia.
Recurrent convulsion rate did not differ between the study
groups.
There were more cesarean deliveries and perinatal deaths in
the low-dose group, but the difference was not statistically
significant.
Other maternal complications, including mortality, were not
significantly different between the groups.
Limitations: small sample size and the study was not
blinded.
Conclusions: more studies needed to determine whether a
low-dose regimen of MgSO4 should be standardized.

58.59% antepartum, 29.29% intrapartum, 12.12%
postpartum eclampsia
68.73% of cases were nulliparous and 84.1% did not receive
ANC at the hospital
82 underwent caesarean section; 13.4% of whom were <20
years old, 39% were between 25-29 years old, and 52.4%
were 30+ years old
Of patients who underwent c/s, 65 (79.3%) had spinal
anaesthesia and 17 (20.7%) had general anaesthesia.
This study concludes that maternal and perinatal survival is
better when the patient undergoes spinal anaesthesia than
those who had general anaesthesia.
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treatment and monitoring
chart (LIVKAN chart).
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Journal, 16(5), 941–946.
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postpartum magnesium
sulphate regimen in the
treatment of eclampsia: a
randomised controlled
trial: original article. African
Journal of Reproductive
Health, 17(3), 131–136.
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Randomized
placebocontrolled
trial

10, 141 women who had not given birth or
were <24 h postpartum, blood pressure
140/90 mmHg or more and proteinuria of
1+ (30mg/dL) or more.

Was conducted in
33 countries,
including Nigeria.
10, 141 women

Randomized to:





Magnesium sulphate (n=5071) or placebo
(n=5070)

Magpie Trial


Katsina, Nigeria
Crosssectional

Randomised
Controlled
Trial

118 participants
(skilled birth
attendants) over five
workshops in 2010

Labour ward of
University of
Maiduguri Teaching
Hospital
January and June
2011
98 eclamptic
mothers

N/A

LIVKAN chart was developed and providers
were trained on its use. Participating
providers were interviewed using a semistructured questionnaire to assess the
usefulness in the chart and assess the
quality of care for severe PE/E.







Incidence
6.41%
(141 out of
2,201
deliveries)

Eclamptic mothers were randomized and
received either the standard or shortened
postpartum regimen. Fetomaternal
outcomes were measured and compared.






While this study does not report findings specific to Nigeria,
it is listed here as it was the Magpie Trial that definitively
demonstrated the safety and effectiveness of MgSO4 for the
management of severe PE/E.
This trial found that MgSO4 reduces the risk of eclampsia
(and probably risk of maternal death) by half with no
substantive harmful effects for mother or baby.

The goal was to assess the usefulness of the treatment
monitoring tool (LIVKAN chart) in improving quality of care
for severe PE/E using questionnaires
98% reported that the LIVKAN chart was better than existing
monitoring system and would be useful for improving care.
73% said the chart would be useful at lower levels and
improve documentation of referral.
Some challenges to using the LIVKAN chart were high
workload (45%) and irregular supply of blank charts (53%).
The chart combines monitoring and treatment guidelines
(anticonvulsant, anti-hypertensive, IV fluids, calcium
gluconate and delivery) and allows for 24h of monitoring
using fewer pages.
21 of the 141 had previously received anticonvulsants
(mainly diazepam) from referring health facilities and 8 had
other complications and were excluded
The remaining 112 participants were randomized to receive
either the standard Pritchard regimen of MgSO4 or a
shortened postpartum course: two doses of IM MgSO4 are
given four hours apart. (14 had incomplete information and
98 were included in the analysis)
Primary outcome measure was recurrence of fits
The shortened course was found to be as effective as
Pritchard for the management of eclampsia
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Study Design

Location,
Timeframe, and
Sample size

Usmanu Danfodiyo
University Teaching
Hospital
Experimental
pilot

January 2002—
December 2003

Prevalence
/
Incidence/
CFR

Main findings/ limitations
Brief summary of methods/intervention

Usmanu Danfodiyo
University Teaching
Hospital, Sokoto
Prospective

January—December
2002
19 patients

Recommendations


Patients were treated with a modified
regimen that limited MgSO4 administration
to 12 hours (vs. 24) and the authors’
primary outcome of interest was recurrent
convulsions.

33 women

Ekele, B. A., & Badung, S.
L. H. (2005). Is serum
magnesium estimate
necessary in patients with
eclampsia on magnesium
sulphate? African Journal
of Reproductive Health,
9(1), 128–132.

Conclusions/







Blood samples were taken from consecutive
patients treated for eclampsia with MgSO4
prior to administration of the loading dose
and subsequent maintenance doses serum
magnesium levels were estimated




Modified Pritchard regimen was used
(loading dose of 4gIV over 10 mins followed
by 10g of deep IM MgSO4; followed by
maintenance doses of 5g every four hours.



Patients were monitored for MgSO4 toxicity
and calcium gluconate was available,





Blood samples were taken before each
maintenance dose
Ezugwu, E. C., Agu, P. U.,
Nwoke, M. O., & Ezugwu, F.
O. (2014). Reducing
maternal deaths in a low
resource setting in Nigeria.
Nigerian Journal of Clinical
Practice, 17(1), 62–66.
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Retrospective
pre/post
intervention
study

Enugu State
University Teaching
Hospital, Nigeria
Jan. 2005—Dec.
2007 & Jan 2008—
Dec. 2009
59 maternal deaths

Reviewed files of all maternal deaths over a
six year period (three years before the
adoption of guidelines aimed at maternal
mortality reduction and three years after)







Pritchard regimen involves use of MgSO4 with a habitual
24h administration of maintenance doses after initial
loading dose
This small study tested an alternate regimen that is the
same loading dose as in Pritchard (4g IV and 5g each
buttock) and maintenance doses every four hours for 12
hours.
Recurrent convulsion rate was 6.0% (comparable to 4.7%
found in the Collaborative Eclampsia Trial
Since cost of magnesium sulfate has been underestimated,
according to the authors, reducing the amount needed to
manage PE/E is better.
Recommend a larger, multicenter randomized (12h vs 24h)
trial is needed to validate these findings.
19 patients completed the study
One patient had recurrent convulsion within 30 mins of
initiative treatment and was given an additional 2g IV to stop
the seizure.
None of the patients experienced loss of deep tendon reflex
or respiratory depression; no signs of MgSO4 toxicity
Mean serum magnesium level at baseline was 1.96mmol/L;
subsequent serum levels (2.1mmol/L) remained within
suggested therapeutic level of 2.0-3.5mmol/L.
Based on this small study, the authors conclude that serum
magnesium levels in eclamptic patients receiving only
MgSO4 to manage their seizures remained within
therapeutic range; recommend more widespread use of
magnesium sulphate without the need to estimate serum
magnesium.

91% retrieval rate, MMR of 645 per 100,000 live births.
Evidence based guidelines were identified through PubMed
and Google scholar and were adapted to the local context.
For this study, resident doctors and nurses were then
trained on the guidelines, which included using the Pritchard
regimen for the management of severe PE/E.
After adoption of the guidelines, there was a 43.5%
reduction in MMR (488 vs 864 per 100,000 live births)
CFR for eclampsia fell by 80% (15.8% to 2.7%)
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Retrospective
evaluation
study

Nnamdi Azikiwe
University Teaching
Hospital (NAUTH),
Nnewi
January 1, 2004—
December 31, 2010


This study compared maternal mortality at
the facility during the pre-SERVICOM and
post-SERVICOM periods.

4,916 live births
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(2013). Attrition from care
after the critical phase of
severe pre-eclampsia and
eclampsia : Insights from
an intervention with
magnesium sulphate in a
primary care setting in
northern Nigeria. Health,
5(9), 1461–1466.

Case-control
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Obstetric mortality in a

Retrospective
review of
births and
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PHC facilities in
Kano State, Nigeria
September 2010—
August 2011
10 PHCs, 150
patients recruited

10 PHCs were included, 5 were in an
experimental arm and 5 were controls; all
facilities received severe PE/E patients and
performed stabilizing treatment (antihypertensives) before sending patient to
referral centers.
The health workers at the experimental
PHCs were trained to recognize patients with
severe PE/E and were trained to administer
loading dose of MgSO4 (10g IM) before
referral. They also received training on
detecting MgSO4 toxicity and how to
administer the antidote, calcium gluconate.






Health workers at control PHCs did not give
MgSO4 and either gave diazepam or no
anticonvulsant.

Federal Medical
Centre, Umuahia,
Abia State.

This study used hospital records to compare
mortality rates from the period before the
1990 launch of the “Safe Motherhood



As a result of Federal proclamation of a social contract with
all Nigerians to provide “basic services to which each citizen
is entitled in a timely, fair, honest, effective and transparent
manner,” all government establishments were required to
prepare a “Service Compact” (SERVICOM) contract with all
Nigerians.
NAUTH launched a SERVICOM charter in May 2005 to
improve service delivery to patients including: elimination of
fee-for-service for all emergency services (including obstetric
services); prompt and appropriate treatment, monitoring of
services and record keeping and penalties for “errant staff”
Overall MMR 1098 per 100,000 livebirths over the six year
period. In 2004, MMR was 1,567 per 100,000 and in
2010, the MMR 691 per 100,000.
PE/E was most common direct cause of maternal death
(25%)
Introduction of SERVICOM reduced the delay at the facility to
receive treatment (change in intake and waiver procedures
led to reduction in presentation-intervention interval)

75% of the women referred to hospitals defaulted; default
rate was higher among those who had been at experimental
PHCs and received the loading dose of MgSO4
It is possible that the immediate, yet temporary, effect of
MgSO4 gave the false idea that the patients were cured and
that follow up was unnecessary; contributing somewhat to
the higher attrition among the experimental group; the
community needs to be educated about the continuing
dangers of severe PE/E
“With appropriate training and supervision, lower-cadre
health care professionals can safely administer MgSO4 to
treat severe pre-eclampsia and eclampsia without significant
toxic effects in primary care settings in developing
countries.”

Overall, puerperal sepsis, hypertensive disorders of
pregnancy (pre-eclampsia and eclampsia), hemorrhage and
uterine rupture, together, accounted for 88% of maternal
deaths.
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/
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Brief summary of methods/intervention
Programme” in Nigeria which aimed to
reduce maternal mortality by 50% before
2000.

January 1, 1981—
December 31, 1998

Conclusions/
Recommendations



21,244 deliveries
Bayero
University/Aminu
Kano Teaching
Hospital, Kano

Retrospective
study; beforeand-after

Main findings/ limitations

Data for the study was obtained from
obstetric records for eclamptic patients.

Baseline: 2006—
2007
Intervention:
February 2008—
January 2009
Baseline: 1,233
patients



For baseline: patients were treated using
diazepam, which was commonly available



Intervention: doctors and midwives were
trained to use MgSO4 following protocol and
detect and treat MgSO4 toxicity (using
calcium gluconate)




Intervention: 1045
patients (49 severe
PE, 996 eclampsia)
Kano, Lagos,
Calabar, Jos,
Maiduguri, Enugu
Multicenter
trial

Baseline: January—
May 2008

‘before-andafter’

Training: April-June
2009

Intervention: August
2009

Incidence
of
eclampsia
baseline:
1.5%
interventio
n: 1.4%

CFR

Baseline: review of hospital records and indepth interviews with providers to inform
development of training curriculum.
Training: mandatory 3-day workshop on
epidemiology of maternal mortality, clinical
features of eclampsia, ways to overcome
limitations in the healthcare system in
managing eclampsia, protocols on MgSO4.
Intervention: use of Pritchard regimen to
treat MgSO4 and guidelines on use and
timing of anti-hypertensives and monitoring
patient.







MMR decreased 8% from 4942 per 100,000 before 1990
and 4545 per 100,000 from 1990-1998
Deaths due to PE/E increased after the launch of the Safe
Motherhood Programme: In 1981-1989, pre-eclampsia
caused 4.4% of maternal deaths and eclampsia caused
13.9%. From 1990-1998, PE caused 10.5% and eclampsia
caused 17.9%

52% of the patients were teenagers, 60.4% were
primigravidae, 74.1% were illiterate, 71% were in
monogamous relationships
This study found a reduction in case fatality among
eclampsia patients from 20.9% (95% CI: 18.7, 23.2) at
baseline to 2.3% (1.4, 3.2) during intervention period.
92.5% of patients treated with MgSO4 did not have
recurrent convulsions
This study found that training providers on protocol for
treating severe PE/E with MgSO4 is effective to reduce CFR
due to eclampsia and there is no significant difference in
cost of MgSO4 vs. diazepam.

Aminu Kano Teaching Hospital, Lagos State University
Teaching Hospital, University of Calabar Teaching Hospital,
University of Jos Teaching Hospital, University of Maiduguri
Teaching Hospital, University of Nigeria Teaching Hospital
Multi-professional trainings included: Ob/Gyns, doctors in
training, nurses, midwives, nurses/midwives in training, staff
from related departments and senior management
The results from pre- and post-tests at the training sessions
indicate a significant increase in knowledge related to
eclampsia management
During one year after the intervention, 219 eclampsia cases
were treated; compared to baseline, a similar incidence of
eclampsia was seen but maternal mortality was significantly
reduced
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Baseline:
15.1%

Endline: clinical records of cases of
eclampsia for one year after the intervention
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Federal Medical
Centre Katsina

All women presenting with severe PE/E were
prospectively enrolled during two periods;
the first receiving a 10g loading dose of
MgSO4 and the second period using a 14g
loading dose.

10g dose:

Descriptive
comparative
study

April 1, 2008—April
30, 2009

Severe PE: BP 116/110 mmHg and
proteinuria of at least 2+

14g dose:
May 1, 2009—
October 25, 2009

Eclampsia: occurrence of convulsions in
women with severe PE








10g dose 54 women



14g dose: 49
women
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management of early-onset
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Nigerians. Journal of
Obstetrics and
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University of Nigeria
Teaching Hospital,
Enugu
Prospective
case control

May 5, 2005—June
30, 2000
175 study group
574 controls

CFR
among
early
onset:
33.3%
CFR
among late
onset:
7.1%

749 consecutive cases of PE were recruited.
The early-onset cases (PE manifested before
30 weeks gestation) formed the study group
and the remaining cases were the controls.
Demographic and obstetric details were
recorded including gestational age at onset
of disease as well as BP and urine test.
After being admitted, patients were routinely
tested for :full blood count, serum
electrolytes, urea and creatinine, liver
function tests, clotting profile, urinalysis and
ultrasonography, they were put on bed rest,








Perinatal mortality rate reduced slightly, but the difference
was not significant (141.5 per 1,000 at baseline, 129.8 per
1,000 after intervention, p=0.32).
13.5% of newborns had low birthweight after the
intervention
“Key message: building the capacity of healthcare providers
to use magnesium sulfate for the treatment of eclampsia is
an effective intervention for reducing the number of deaths
due to eclampsia in low-income countries”
55 women had severe PE (25 were in 10g group. 30 in 14g
group)
48 had eclampsia (29 in 10g group and 19 in 14g group)
Two (7%) of the women in the 10g group had recurrent
convulsions and none who were in the 14g group
experienced recurrent convulsions (difference is not
significant).
Rates of vaginal delivery, onset of convulsion/recurrent
convulsion, maternal death and neonatal Apgar score did
not have statistically significant rates between the two
groups.
10g IM loading dose prevented eclampsia in 80% of women
with severe PE and prevented recurrent convulsions in 93%
of women with eclampsia.
Using 10g did not increase chances of caesarean section or
severe birth asphyxia at 5 minutes.
The six perinatal deaths observed were all in women in the
10g groups, but these women were admitted with
intrauterine fetal demise before treatment was delivered.
RCT is needed to confirm efficacy and safety of lower loading
dose for potential use at lower level facilities.
‘Pure’ PE: hypertension associated with proteinuria in
previously normotensive women.
Superimposed PE: significant aggravation of preexisting
hypertension associated with sustained proteinuria
Alpha-methyldopa and hydrallazine were used to control high
BP above 160/110 mmHg (methyldopa was used
antepartum and hydrallazine used to manage hypertensive
crises, eclampsia and during peripartum).
Seizures were controlled using diazepam (MgSO4 was
unavailable).
Early onset group experienced 14 maternal deaths (7 due to
eclampsia, 3: renal failure, 2: HELLP syndrome, 1:
anesthetic accident, 1: septicemia from AIDS) –80% of early
onset group gained two weeks gestation.
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Before and
after

Kano, Bichi, Wudil,
Gwarzo, Rano,
Minjibir, Tudun
Wada, Doguwa,
Rano, Rogo
February 1, 2008—
January 31, 2009

baseline
CFR:
20.9%
post
interventio
n CFR:
2.3%

Five hospital officials from the Hospitals
Management Board and one doctor and one
midwife from each of the ten facilities were
invited to participate in a training. The twoday training provided didactic lectures on
evidence-based management of
hypertensive disorders of pregnancy and use
of MgSO4. Participants were taught to
administer 4g MgSO4 IV and 10g IM followed
by 5g IM every 6 hours until 24 hours after
delivery or the last seizure and also to
monitor for toxicity by checking deep tendon
knee reflex.
Data was then collected on maternal
sociodemographics, pattern of severe PE/E,
and fetomaternal outcomes at the ten
facilities and compared to baseline survey
from three general hospitals

Kano State

Feb—December
2008

1045 patients
treated with MgSO4

CFR: 2.3%

MgSO4 was introduced to ten general
hospitals and data was collected from the
facilities to monitor the intervention. A
workshop on MgSO4 use and monitoring was
conducted and 25 master trainers took the
knowledge they acquired and conducted
step down trainings to 160 clinical
providers.















Causes of death in the late onset group were: eclampsia=7,
renal failure=6, abruptio placentae=5, anesthesia-related
causes=4, cerebrovascular accident=2, HELLP syndrome=2,
associated diabetic ketoacidocis=1, septicaemia from
AIDS=1
Based on the high CFR among early onset cases, the
authors recommend that these cases be managed
conservatively to improve fetal and maternal outcomes

Baseline surveys showed that 1,233 patients with severe
PE/E, 258 died : baseline CFR: 20.9%
25 master trainers participated in the training and
subsequently trained 160 health workers (doctors,
midwives, and community health extension workers)
During the project period, 49 cases of severe PE and 996
cases of eclampsia were treated at the facilities out of a
total of 22, 502 deliveries
322 cases of eclampsia manifested antepartum, 430 were
intrapartum, and 244 developed postpartum
After the intervention, only 24 of the 1045 cases died,
significantly reducing the CFR associated with severe PE/E.
Perinatal mortality was 12.3% (129 of 1045); perinatal
mortality was significantly higher among patients who
experienced three or more convulsions (there was no
baseline perinatal mortality rate, but another facility that
uses diazepam reported a 35.3% stillbirth rate).
Introducing MgSO4 for severe PE/E is a low-cost and
replicable intervention that has a positive effect on maternal
and fetal morbidity and mortality and should be scaled up.
60.4% of the patients treated with MgSO4 were primigravida
and 44.1% had no form of ANC
23 women (2.2%) experienced toxic effects associated with
MgSO4 but they were treated with calcium gluconate and no
morbidity or mortality resulted
24 mothers died, and 129 (12.3%) of the babied were
delivered dead
The 24 deaths in this study made up 4.9% of all maternal
deaths during the 12 month period of the project
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evidence for the effectiveness of MgSO4.
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Federal Medical
Centre Azare,
Bauchi

Primigravida patients with singleton
pregnancies presenting with antepartum or
imminent eclampsia and a closed cervical os
were randomized for delivery by CS or by
induced labor using misoprostol.






50 eclamptic
patients
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Retrospective
case review
Before-andafter

University of Nigeria
Teaching Hospital
Enugu
January 1 2005—
December 31, 2008
Diazepam: 47
women
MgSO4: 30 women

Prevalence
of severe
PE: 3.3%

CFR
before:

CFR after:


This retrospective case review looked at
cases of severe PE and the maternal and
perinatal outcomes for two years before and
two years after the introduction of MgSO4 as
standard treatment for severe PE in 2007
(previously diazepam).






Compared to maternal deaths due to eclampsia during the
12 months prior to the intervention (268/567; 47.3%), the
attributable deaths from eclampsia reduced by 42.4%
This project was successful because it was evidence-based,
sustainable through stakeholder involvement, and
replicable.

Misoprostol failure rate was 4 patients (16%); these four
were subsequently delivered by CS.
The CS group spent an average 10.1 days in the center
compared to 6.08 days spent on average in the center by
the misoprostol group.
Maternal complications and admissions of babies were
frequent in the CS group.
Maternal mortality in each group was 4%
Given the findings of this pilot study, the authors
recommend using misoprostol (cheap, available, and safe
for delivery of antepartum eclamptics) in the event of a delay
for CS. A larger, multi-center study is also suggested.
77 cases of severe PE over the four year period; 49.4% were
primigravidae
One woman from the diazepam group experienced tonicclonic seizures, none of the women in the MgSO4 group
experienced seizures after the initiation of the treatment; no
maternal death occurred in either group.
Women in the diazepam group were more likely to
experience prolonged hospital stay compared to the MgSO4
group.
25 of the 79 babies died within the perinatal period (2 sets
of twins) giving a perinatal case fatality rate of 32.5%--but
there was not a significant difference in perinatal mortality
between the groups.
This study showed that MgSO4 is the most effective and
safest drug to manage convulsions in severe PE and results
in reduced maternal and perinatal morbidity when compared
to diazepam.

Appendix IV:
SUMMARY TABLES OF DEMONSTRATED AND POTENTIAL RISK FACTORS FOR PE/E
Citation

Study Design

Location,
Timeframe, and
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Prevalence
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Incidence/
CFR

Primary Health
Centers in Katsina,
Adamawa and Borno
States

Abubakar, A., Abdullahi, R., HZ, J.,
Dauda, M. H., & MA, P. (2009).
Maternal Ethnicity and Severity of
Pre-Eclampsia in Northern Nigeria.
Asian Journal of Medical Sciences,
1(3), 104–107.

February—August
2009
61 cases of severe
PE

N/A

Main findings/ limitations
Brief summary of Methods

Conclusions/
Recommendations

Blood pressure measured and
monitored. BMI calculated. Total serum
cholesterol, triglyceride, high and low
density lipoproteins were determined
from a blood sample taken after
overnight fasting. Urinalysis began.
-22 in Group A (Hausa)





-20 in Group B (Kanuri)
-19 in Group C (Fulani)

Ademuyiwa, O., Odusoga, O. L.,
Adebawo, O. O., & Ugbaja, R. (2007).
Endogenous antioxidant defences in
plasma and erythrocytes of pregnant
women during different trimesters of
pregnancy. Acta Obstetricia et
Gynecologica Scandinavica, 86(10),
1175–1182.

Obstetrics
Departments of
Sacred Heart
Hospital Abeokuta,
Nigeria and Olabisi
Onabanjo University
Teaching Hospital,
Sagamu Nigeria
Case-Control

97 pregnant
women, 7 with new
onset of PE
Controls (n=20)
female students
from University of
Agriculture,
Abeokuta, Nigeria
and Olabisi
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Blood samples taken from all
participants for exzymatic
determinations. The study looked at:
enzymic antioxidants (SOD, CAT, GST),
non-enzymic antioxidant (GSH), and a
heme biosynthetic enzyme,
aminolevulinic acid dehydratase (ALAD)
to determine characterize the profiles of
antioxidant response in pregnant
women.






No significant difference in the severity of
pre-eclampsia between the Hausa and
Kanuri, though they demonstrated
elevated levels of triglyceride, serum
cholesterol, pathological edema, increase
in blood pressure, and higher levels of
urine protein.
The Fulani group showed higher levels of
the above and were more likely to
progress to eclampsia than the other two
tribes.

This study showed an increased plasma
activity of Mn-SOD and statistically
significant low values of erythrocyte CAT,
SOD and ALAD activities in PE compared
to healthy pregnant women
Other antioxidants in plasma and
erythrocytes remain unchanged
The data from this study supports
hypothesis that ‘oxidative stress’ (OS)
occurring secondary to impaired oxidant
defenses, might be one mechanism
underlying the pathophysiology of preeclampsia (small sample size, needs
further studies)
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Onabanjo University,
Ikenne, Nigeria.
Adeyinka, D., Oladimeji, O.,
Adekanbi, T., Adeyinka, F., Falope, Y.,
& Aimakhu, C. (2010). Outcome of
adolescent pregnancies in
southwestern Nigeria: A case control
study. Journal of Maternal-Fetal and
Neonatal Medicine, 23(8), 785–
789.

University College
Hospital, Ibadan,
Nigeria
Retrospective
case control

January 2007—
November 2008
45 cases,
90 controls

Incidence
of PE/E
among
cases: 20%
Incidence
of PE/E
among
controls:
3.33%



Cases were women aged <18 years and
controls were between 20 and 35 years




Adokiye, E., Isreal, J., C, H. T., & Levi,
W. O. (2015). Factors influencing the
prevalence of Preeclampsiaeclampsia in booked and unbooked
patients: 3 years retrospective study
in NDUTH, Okolobiri. World Journal
of Medicine and Medical Science,
3(1), 1–14.

Retrospective
case review

Department of
Obstetrics and
Gynaecology, Niger
Delta University
Teaching Hospital,
Okolobiri, Nigeria
January 1, 2011—
December 31, 2013



Incidence
of PE/E:
5.69%
Eclampsia
only:
2.16%


Review of medical records for all
pregnant women admitted and
managed to delivery during the study
period.





1,667 deliveries





Afolabi, B. B., Iwuala, N. C., Iwuala, I.
C., & Ogedengbe, O. K. (2009).
Morbidity and mortality in sickle cell
pregnancies in Lagos, Nigeria: a
case control study. Journal of
Obstetrics and Gynaecology : The
Journal of the Institute of Obstetrics
and Gynaecology, 29(2), 104–106.

38

Retrospective
case control

Department of
Obstetrics and
Gynaecology, Lagos
University Teaching
Hospital, Idi-Araba,
Lagos, Nigeria

Examination of delivery records for all
pregnant HbSS women delivering during
study period and the case notes of the
next two delivering age-and paritymatched HbAA women were retrieved.





Defined pre-eclampsia as hypertension (>
140/90mmHg on two occasions 4 hours
apart) and proteinuria (>0.3g/dl) in the
second half of pregnancy. Eclampsia =
associated with convulsions, oliguria
(>400ml/24h), increased tendon reflex,
pain in the right hypochondriac region.
Adolescents were significantly more likely
to develop PE/E than their non-adolescent
counterparts.
Seven (7.37%) of PE/E cases were
teenagers, 48 (48.42%) were 20-29
years, 40 (42.11%) were 30+ years old
89.5% live in rural areas
66.32% had either primary or post
primary education
60% had more than two previous
deliveries
Perinatal mortality was 36.84%; 41.05%
were preterm deliveries (29-36 weeks)
77.68% were unbooked, 69.47% had
visited TBAs
Proteinuria in PE/E patients: 3+ =
30.53%; 2+= 40.00%; 1+ 27.37%; no
proteinuria = 1.05%
85.79% treated with Pritchard regime for
MgSO4
81.10% received Aldomet (Methyldopa);
97.89% were given Hydralazine
21.05% were given diazepam
Among HbAA women 5.6% developed PE
and 1.3% developed eclampsia; among
HbSS women, 6.7% developed PE and
none developed eclampsia
This study did not find that HbSS women
were at a higher risk of developing PE; the
power of this study is not enough to make
conclusions
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January 1996—
December 2000

75 women with
HbSS and 150
women with HbAA
Usmanu Danfodiyo
University Teaching
Hospital, Sokoto
Airede, L., & Ekele, B. (2003).
Adolescent maternal mortality in
Sokoto, Nigeria. Journal of Obstetrics
and Gynaecology, 23(2), 163–165.

Akerele, J., Abhulimen, P., &
Okonofua, F. (2001). Prevalence of
asymptomatic bacteriuria among
pregnant women in Benin City,
Nigeria. Journal of Obstetrics and
Gynaecology, 21(2), 141–144.

Akiibinu, M. O., Kolawole, T. O.,
Ekun, O. A., & Akiibinu, S. O. (2013).
Metabolic dysfunctions in Nigerian
pre-eclamptics. Archives of
Gynecology and Obstetrics, 288(5),
1021–1026.

Retrospective,
cross-sectional
study

Semiquantitative
screening

January 1990 to
December 1999

ANC clinics in Benin
City
500 pregnant
women

Semi-quantitative culture of midstream
urine from pregnant women to screen
for asymptomatic bacteriuria in first
trimester.
N/A

Samples with significant bacteriuria
(105 or more bacteria per ml) were
examined under the light microscope
for: presence and number of red blood
cells, white blood cells, epithelial cells,
and casts.
Pre-eclamptic women were recruited
after 20 weeks.

Case-control

32 pregnant women
with pre-eclampsia
(cases)
5 months
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Information relating to age, parity,
literacy level, booking status, duration
and outcome of labour, mode of delivery
and cause of death were obtained from
casenotes and data were reviewed and
analyzed

Total antioxidant potential (TAP), total
plasma peroxides (TPP), total
cholesterol (TC), total protein (TP),
albumin, globulin, nitric oxide (NO), Creactive protein (CRP), total triiodotyronine (TT3) and thyroid









MMR 4863 per 100,000 livebirths
46 (23.4%) of all maternal deaths were
adolescents (12-19 years old)
Eclampsia causes 21 (46%) of the
adolescent maternal deaths

“Rational therapy of asymptomatic
bacteriuria in pregnant women may
prevent associated risks such as
pyelonephritis and pre-eclampsia.”
Of the 500 women screened, 433
specimens showed significant bacteriuria.



[note: this study did not report the
number of participants who developed
PE/E)]



Cases were defined as having
hypertension (systolic BP = 169 + 26.0
mmHg, diastolic = 102 + 11.0 mmHg),
significant proteinuria (368 + 39 mg/24h,
severe headache, abdominal pain and
vomiting.
Weight, BMI, mean values of sBP, dBP
urinary protein, TSH, T3-CHOL, TPP, OSI,
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40 normal
pregnancies
(controls)

Main findings/ limitations
Brief summary of Methods

Conclusions/
Recommendations

stimulating hormone (TSH) were
determined.
Oxidative stress index (OSI) was
calculated as the percent ratio of TPP
and TAP.








Akinloye, O., Oyewale, O. J., &
Oguntibeju, O. O. (2010). Evaluation
of trace elements in pregnant
women with pre-eclampsia. AFRICAN
JOURNAL OF BIOTECHNOLOGY,
9(32), 5196–5202.

Anorlu, R. I., Iwuala, N. C., & Odum,
C. U. (2005). Risk factors for preeclampsia in Lagos, Nigeria.
Australian and New Zealand Journal
of Obstetrics and Gynaecology,
45(4), 278–282
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Case control
study*
*the paper
itself claims to
be a ‘crosssectional
randomized
study’

Blood collection was done using a
sterile needle and syringe into
appropriate tube, each sample was
analyzed and zinc, copper, selenium,
manganese and magnesium levels were
determined

49 pre-eclamptic
patients (cases)
40 age-matched
non pre-eclamptic
women (controls)

Lagos University
Teaching Hospital
Case-control



Ladoke Akintola
University of
TechnologyTeaching
Hospital, Osogbo,
Osun State, Western
Nigeria

February 2001 to
August 2002
1803 women who
delivered during
study period








137 of
1803 had
PE/E (128
were
analyzed)
Incidence:
7.6%



Socio-demographic characteristics, prepregnancy weight, medical history and
previous obstetric history, and level of
stress at home and at work was
collected during face-to-face interviews

MDA and CRP in pre-eclamptics were
significantly higher than in the controls.
Mean values of plasma TT3, albumin, TP
TAP and NO were significantly lower
among cases when compared with
controls.
Globulin showed no significant difference
between cases and controls
Results indicating that pre-eclamptics had
hypothyroidism, hypercholesterolemia,
oxidative stress and deranged
inflammatory responses.
Conclusion: hypercholesterolemia,
oxidative stress, deranged inflammatory
responses and lower thyroid function are
possible features of PE
All elements evaluated (zinc, copper,
selenium) were significantly lower in the
PE group when compared to the control
group.
Dietary supplementation of these
elements may help prevent PE
Mean BMI, systolic blood pressure and
diastolic blood pressure were all
significantly higher among cases than
controls
Mean serum concentrations of zinc,
copper, selenium, manganese and
magnesium were all significantly lower
among cases than controls
Suggests that PE is associated with
oxidative stress
91 (71.1%) were primigravidae
Risk factors associated with increased
risk of pre-eclampsia were: nulliparity (OR
4.77; 95% CI 2.90–7.78), stressful work
during pregnancy (OR 2.10; 95% CI 1.20–
3.71), stressful home environment (OR
1.97; 95% CI 1.27–3.69), previous preeclampsia (OR 11.68; CI 3.81–37.61),
history of chronic hypertension (OR 2.21;
95% CI 1.17–6.20), a body weight greater
than 80 kg (OR 2.01; 95% CI 1.05– 3.87);
and multiple pregnancy (OR 2.71; 95% CI
1.27—6.13)
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Participants divided into three groups:
--32 pregnant women in 3rd trimester
with preeclampsia
Obstetrics and
Gynaecology Clinic
of the University
College Hospital,
Ibadan, Oyo State,
Nigeria

Arinola, G., Arowojolu, A., Bamgboye,
A., Akinwale, A., & Adeniyi, A. (2006).
Serum concentrations of
immunoglobulins and acute phase
proteins in Nigerian women with
preeclampsia. Reproductive Biology,
6(3), 265–27

92 women 15-30
years old

--36 pregnant women in 3rd trimester
without preeclampsia
--24 non-pregnant women with no
history of abortion as controls
Blood and urine samples were taken
and analyzed for: immunoglobulin
classes (IgA, IgG, and IgM) and acute
phase proteins (alpha-2-macroglobulin,
haptoglobin and transferrin).
Mean of two readings for each
specimen were taken as actual value

Atiba, A. S., Abbiyesuku, F. M.,
’Niran-atiba, T. A., Oparinde, D. P.,
Ajose, O. A., & Akindele, R. A. (2014).
Free radical attack on membrane
lipid and antioxidant vitamins in the
course of pre-eclamptic pregnancy.
Ethiopian Journal of Health
Sciences, 24(1), 35–42.
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Longitudinal
prospective
cohort

Ladoke Akintola
University of
Technology
Teaching Hospital,
Osogbo and
Egbedore Local
Government Health
Centre, Awo, Osun
state, Nigeria
May 2011–January
2012
118 pre-eclamptic
and 115 apparently
normal pregnant
women were
recruited









100 women for each of the three study
groups (PE, normal pregnancy (NP),
nonpregnant (NoP)) participated in
baseline and follow up eight weeks
later.
Venous blood was collected from
pregnant participants and nonpregnant
controls. Plasma was separated and
used for malondialdehyde (MDA) and
vitamins C and E analysis.






Diagnosis of PE was done based on:
significant proteinuria (>100mg/day) and
high blood pressure (>130/90 mmHg) on
at least two occasions 6 hours apart or
more.
Mean level of IgG was significantly lower
in subjects with preeclampsia and
significantly higher in patients with normal
pregnancy when compared to nonpregnant controls.
Mean level of IgA was significantly
reduced in pre-eclamptic subjects vs.
controls
Mean levels of transferrin and alpha-2macroglobulin were significantly lower
and among PE group compared with other
two groups.
Haptoglobin was significantly higher in
women with PE compared to normal
pregnancy, but both pregnant groups had
lower levels compared with non-pregnant
women.

Pre-eclamptic women were defined as
having elevated BP of 140/90 mmHg on
two consecutive recordings 4 to 6 hours
apart, minimum proteinuria of 300gm in
24 hour urine sample or 1+ on dipstick.
Highest levels of MDA were in PE patients
and lowest in NoP patients; MDA among
PE patients was also higher than NP
during the second and third trimesters.
No change in plasma levels of vitamins C
and E was found as pregnancy advances
Studies needed to identify the specific
antioxidant to counteract lipid
peroxidation (free radical injury) which
may help reduce PE.
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Age matched non
pregnant women


Attahir, A., Sufiyan, M. B., Salihu, A.,
& Rabiu, a M. (2010). Association
between Maternal Socio – economic
Status , Polygamy and Risk of Pre –
eclampsia in Rural Areas of Northern
Nigeria. Journal of Family and
Reproductive Health, 4(1), 47–52.

Primary Health
Centers in Katsina,
Adamawa and Borno
states
Case control

Two groups of 50
each:
A--Pregnant nonhypertensive women



BP was measured and questionnaire
was administered to each patient to
assess the association between various
social factors and risk of PE

B—women with preeclampsia





University of Benin
Teaching Hospital
Awodu, O. A., Shokunbi, W. A., &
Ejele, O. A. (2003). Lupus
anticoagulant in Nigerian women
with preeclampsia. West African
Journal of Medicine, 22(3), 240–
242.

Chigbu, C. O., Okezie, O. A., & Odugu,
B. U. (2009). Women in southern
Nigeria with change in paternity do
not have increased incidence of preeclampsia. Journal of Obstetrics and
Gynaecology : The Journal of the
Institute of Obstetrics and
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Case control

26 pregnant
women, 18-45 years
old with PE
50 apparently
healthy pregnant
women, 18-45 years
old

Prospective
cohort

Catholic Maternity
Hospital, Moniaya,
Ogoja, Cross River
State, Nigeria
September 2006—
August 2007

Blood samples were collected and
platelet poor plasma was prepared and
preserved for testing/analysis.



Kaolin clotting time (KCT) was done to
test coagulation
Lupus anticoagulant was determined to
be present if the KCT ratio at 20% test
plasma to KCT at 100% normal control
plasma > 1.2
Women attending ANC clinic of the
hospital for their second pregnancy
were recruited, sociodemographic and
obstetric data was collected including
paternity of index and previous
pregnancies, outcome of previous






If PE progresses to eclampsia,
characterized by malignant hypertension
and epileptiform convulsions, caesarian
section is required.
Known risk factors: nulliparity, history of
pre–eclampsia in previous pregnancy,
extremes of maternal age, multi fetal
gestation, chronic hypertension, diabetes
mellitus, chronic kidney disease, vascular
or connective tissue disease,
thrombophilia, high Body Mass Index
(BMI), and obesity.
Family history of hypertension, diabetes or
kidney disease was more common among
women with PE
Seclusion and polygamy were not found to
have an effect on risk of developing PE
The women with PE were more likely to be
uneducated, lack income, which could
lead to low ANC attendance among this
population
This study found 15.4% prevalence of
lupus anticoagulant in women with PE
which is statistically higher than the
prevalence of LA in apparently healthy
pregnancies. (it is controversial as to
whether LA presence is causal or
consequence of clinical manifestations
with which it has been associated)
This study recommends that LA in PE in
Nigeria is significant and all women
should be screened for LA.
The “exposure” for this cohort study was
change in paternity
PE was defined as hypertension
(>140/90 mmHg on at least two
occasions at least 6h apart or dBP of
110mmHg at any time or an increase of
30mmHg and 15mmHg in sBP and dBP
respectively or mean arterial pressure of
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Gynaecology, 29(2), 94–97.

Enaruna, N., Ande, A., & Okpere, E.
(2013). Clinical significance of low
serum magnesium in pregnant
women attending the University of
Benin Teaching Hospital. Nigerian
Journal of Clinical Practice, 16(4),
448–53.

Location,
Timeframe, and
Sample size

Prevalence
/
Incidence/
CFR

779 women were
recruited and 732
were included in the
final analysis due to
loss to follow up

Prospective
cohort

Main findings/ limitations
Brief summary of Methods

Recommendations
pregnancy and duration of sexual
cohabitation with present partner.

Urine protein was measured using
dipstick testing and ANC follow up was
every four weeks until 28 weeks
gestation and every two weeks after that
until 37 weeks.

University of Benin
Teaching Hospital,
Benin City

Participants (included antenatal women
recruited in 2nd trimester and followed
up until 1 week postpartum) had blood
drawn at recruitment to measure serum
magnesium and were followed up until
delivery when repeat serum magnesium
assay was done

June—December
2011
160 patients

Conclusions/











Familoni, O. B., Adefuye, P. O., &
Olunuga, T. O. (2004). Pattern and
factors affecting the outcome of
pregnancy in hypertensive patients.
Journal of the National Medical
Association, 96(12), 1626–1631.

Olabisi Onabanjo
University Teaching
Hospital, Sagamu
Retrospective
cohort

January 1997—
December 2002

HDP
incidence:
5.3%

Medical records of pregnant patients
were analyzed, 127 were identified as
having a hypertensive disorder of
pregnancy (HDP).


Based on hypertension type, patients
were categories as “high-risk” or “lowrisk” the groups were compared

2,393 deliveries







Glew, R. H., Cole, D. M., Mehla, G. S.,
El-Nafaty, A. U., Crossey, M. J.,
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Case control

Federal Medical
Centre, Gombe and

N/A

Pregnant women were placed into one
of four groups: Group 1: PE; Group 2:




greater than 105 mmHg) with proteinuria
after 20 weeks of pregnancy
312 (group A) had change in paternity;
420 had no change in paternity (group B)
The rate of PE was not significantly
different between the two groups, within
Group A, duration of cohabitation did not
show significant difference between those
who developed PE and those who did not.
“the findings of this study call for a reexamination of the ‘change in paternity
theory of pre-eclampsia’”
Primary outcome measure was
prevalence of hypomagnesemia in
pregnancy
Magnesium deficiency was detected in
16.25% of the patients and was
significantly correlated with occurrence of
PE, leg cramps, and preterm birth.
Recommends magnesium
supplementation (or eating magnesiumrich diet)
26.2% had gestational hypertension,
19.7% had pre-eclampsia superimposed
on chronic hypertension and 54.1% had
PE/E.
Those with PE/E had the worst maternal
and fetal outcomes (6.1% maternal
mortality, 18.2% target organ damage,
36.4% fetal mortality, 66.7% fetal
respiratory distress)
62 (50.8%) were high-risk and 60 (49.2%
were low-risk
High-risk group had higher rates of:
illiteracy, maternal death, stroke,
abruptio, fetal death, and caesarean
section and lower rates of regular ANC.
Parity had no effect on whether the
patient was high- or low-risk
PE was defined as BP 140/90 mmHg or
greater and proteinuria (>190mg/g
creatinine)
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Tzamaloukas, A., & VanderJagt, D. J.
(2005). Lysosomal enzymes in
preeclamptic women in northern
Nigeria. Clinica Chimica Acta;
International Journal of Clinical
Chemistry, 353(1-2), 95–101.
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Specialist Hospital,
Gombe
June-August 2001
Group 1: 41 women
Group 2: 31 women
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hypertensive aproteinuric; group
3:normotensive proteinuric; group 4:
healthy pregnant women (controls)



Urine specimens were collected and
underwent biochemical analyses.
Results were statistically analyzed



Group 3: 44 women
Group 4: 52 women
Glew, R. H., Melah, G., El-Nafaty, A.
I., Brandt, Y., Morris, D., &
VanderJagt, D. J. (2004). Plasma
and urinary free amino acid
concentrations in preeclamptic
women in northern Nigeria. Clinica
Chimica Acta; International Journal
of Clinical Chemistry, 342(1-2),
179–185.



Case control

Federal Medical
Centre, Gombe and
Specialist Hospital,
Gombe

Urine and blood samples were taken
and analyzed for amino acids.

37 pre-eclamptic
women

Statistical analyses were performed to
compare variables between patients
with PE and controls

16 controls






Jahun Hospital

Guerrier, G., Oluyide, B., Keramarou,
M., & Grais, R. F. (2013). Factors
associated with severe preeclampsia
and eclampsia in Jahun, Nigeria.
International Journal of Women’s
Health, 5(1), 509–513.

October 2010—May
2011
Hospital-based
case control
study

2,835 pregnant
women
1,257: normal
pregnancy (controls)
419: Severe PE/E
(cases)

16% had
severe
PE/E (175:
severe PE,
and 244:
eclampsia)

Participants were selected from the
emergency obstetric program in the
rural Jahun hospital, patients were
interviewed and gave demographic
information, medical history, social
history, current history, use of traditional
treatments, delivery details and
neonatal outcome.







44

The goal was to assess whether lysosomal
enzyme concentrations in women with PE
were due to the hypertension or
proteinuria, or both.
This study found that low levels of βhexosaminidase in pre-eclamptic women
is associated with proteinuria and not
hypertension; it is not likely, therefore,
that screening for lysosomal enzymes
would be useful in predicting or
monitoring PE.
Defined “pre-eclamptic” as: cerebral or
visual disturbances, epigastric pain,
pulmonary edema or cyanosis, sBP >
140mmHg or dBP >90 mmHg and
proteinuria (190mg total protein/g
creatinine or more)
Serum concentrations of common amino
acids (including serum arginine) were not
significantly different between study
groups, except phenylalanine.
Phenylalanine concentration was
significantly higher among PE group
Eclampsia is the occurrence of seizure
and/or altered level of consciousness not
caused by epilepsy or other convulsive
disorders, with signs of severe
preeclampsia.
Severe PE : new hypertension with blood
pressure of 160 mmHg systolic or
diastolic BP of 110 mmHg or greater,
after 20 weeks of gestation in a woman
who was normotensive before 20 weeks,
associated with proteinuria
Of 244 eclamptic cases, 194 were anteand intra-partum, and 50 were admitted
postpartum; 11% experienced no signs of
severe hypertension (headache, blurred
vision)
The groups were similar except for: the
cases were younger (mean age 21 vs
mean age 25 among controls), a higher
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Idogun, E. S., Imarengiaye, C. O., &
Momoh, S. M. (2007). Extracellular
calcium and magnesium in
preeclampsia and eclampsia.
African Journal of Reproductive
Health, 11(2), 89–94.

Cross sectional

University of Benin
Teaching Hospital,
Nigeria
11 patients
23 controls,

Ikechukwu, I. C., Ojareva, O. I. A.,
Ibhagbemien, A. J., Okhoaretor, O. F.,
Oluwatomi, O. B., Akhalufo, O. S., …
Chigaekwu, M. N. (2012). Blood
lead, calcium, and phosphorus in
women with preeclampsia in Edo
State, Nigeria. Archives of
Environmental & Occupational
Health, 67(3), 163–169.
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Cohort

Irrua Specialist
Teaching Hospital
Irrua, Edo State,
Nigeria

N/A

Patients were randomly selected from
among hospital attendees, “patients”
were women presenting with PE (or
PE/E) in their third trimester who were
going for caesarean section; those on
MgSO4 and calcium lactate drugs were
excluded. Controls were normotensive
pregnant women, also going for CS.
Blood was taken from participants, and
plasma was harvested and analyzed for
calcium, magnesium and electrolyte and
urea estimations; cerebrospinal fluid
(CSF) was taken during lumbar puncture
for spinal anaesthesia and calcium and
magnesium estimations were made.
Women aged 20-35 attending ANC clinic
at the hospital. Women with history of
any chronic disease and glycosuria were
excluded.











November 2006—
September 2008

Medical histories were taken and
recorded in duplicate by doctors who
were unaware of the goal of the study.



proportion attended fewer than four ANC
visits (79% vs 73%)
63% used traditional treatments during
their pregnancy (herbal medicines to treat
bleeding, ease abdominal pain, or for
rupture of the amniotic sac)
Cases were statistically more likely to
have cesarean section, longer hospital
stay, stillbirth or neonatal death.
Use of herbal treatment was not found to
increase the risk of developing severe
PE/E.

Plasma calcium was significantly higher in
controls vs. patients but there was no
significant difference between groups for
plasma magnesium levels.
Calcium CSF and magnesium CSF were
significantly lower in patients than in
controls
Lower levels of magnesium and calcium
may have an effect on PE/E

PE was defined as SBP > 140 mmHG
and/or DBP > 90 mmHg and proteinuria
during at least two visits after 22nd week
of gestation.
150 normal pregnant women and 59 with
preeclampsia
Blood lead levels were significantly higher
in women with PE than normal pregnant
women and serum calcium and inorganic
phosphorus were significantly lower than
in normal pregnant women.
A possible explanation for the increase in
blood lead in PE women vs normal
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women, 74 excluded
for noncompliance
209 nonpregnant
controls

Ikpen, M. A., Eigbefoh, J., Eifediyi, R.
A., Isabu, P. A., Okogbenin, S.,
Okogbo, F. O., … Ekwedigwe, K. C.
(2012). Determination of antioxidant
status of pre-eclamptic and
normotensive sub-rural Nigerian
pregnant women at the Irrua
Specialist Teaching Hospital, Irrua,
Edo State. The Journal of MaternalFetal & Neonatal Medicine, 25(10),
2046–2050.

Isezuo, S. A., & Ekele, B. A. (2004).
Eclampsia and abnormal QTc. West
African Journal of Medicine, 23(2),
123–127.

Leone, S., Res, J. B., No, V., O, O. V.,
S, A. A., Adewumi, A., & Olalekan, A.
(2009). Homocysteine Levels in
Nigerian Women with Pre-eclampsia
/ Eclampsia. Sierra Leone Journal of
Biomedical Research, 1(1), 55–60.
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prospective
case—control
study

Prospective
case control

Case control

Antenatal clinics,
antenatal and
labour wards,
Accident and
Emergency unit of
Irrua Specialist
Teaching Hosptal,
Irrua, Edo State.

Usman Danfodiyo
University Teaching
Hospital, Sokoto,
Nigeria
August 2001 and
July 2002

Prevalence
/
Incidence/
CFR

Main findings/ limitations
Brief summary of Methods

Conclusions/
Recommendations

BP was measured, protein and sugar
levels tested in urine. Blood samples
were taken from each participant at
delivery and analyzed for calcium and
phosphorus determination and blood
lead determination.

Eighty cases and 80 matched controls
were recruited into the study.





Cases: booked pregnant women with PE
Controls: gestational age and parity
matched normotensive pregnant women



Blood samples were taken from all
participants and analyzed for vitamins C
and E.



30 consecutive patients with
intrapartum eclampsia were included in
the study.



General information was obtained as
well as medical history. BP was
measured three times at rest and the
average of the last two were taken as
the BP.



30 patients

Electrocardiogram (ECG) was recorded
during the intrapartum period to
measure QT interval

Lagos University
Teaching Hospital,
Idi-Araba

“all participants were to strictly maintain
the drug regimen prescribed for routine
antenatal use only”

January—October
2006

Venous blood was collected and plasma
levels of homocysteine were determined







pregnant women is a possible increase in
maternal bone lead mobilization.
Elevated blood lead levels may contribute
to the development of PE

Two consecutive BP measurements of
>140.90 mmHg 4 hours apart after 20th
week and significant proteinuria (>2+) or
1+ if the specific gravity was < 1.030 and
pH was <8.
Plasma vitamin C and E levels were
significantly lower in cases than in
controls.
Role of antioxidants in pathogenesis of PE
is inconclusive, but may be an opportunity
to prevent PE
Eclampsia is characterized by generalized
convulsion, elevated BP and proteinuria
with or without oedema occurring after 20
weeks gestation.
QT interval is the “total time from the
onset of ventricular depolarization to the
completion of repolarization”
Cases had higher mean heart rate, higher
frequency of sinus tachycardia and
significantly higher QTc.
This study found that eclampsia is
associated with hypocalcaemia, abnormal
QTc and T-axis deviation; serum
magnesium did not differ significantly
between study groups
Rising homocysteine level in eclamptics
was significantly associated with blood
pressure levels.
Plasma homocysteine levels in the 3rd
trimester of pregnancy is significantly
higher among eclamptic women than
those who have a normal pregnancy.
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100 primigravidae
women (60 lost to
follow up, or
incomplete data)
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at registration, at 26 weeks and at 34
weeks gestation for all participants.



Mean corpuscular volume, plasma
homocysteine level and rising blood
pressure during pregnancy may help
predict development of PE/E.



165 maternal deaths among adolescent
mothers: MMR = 5415 per 100,000 live
births
Main cause of death was eclampsia:
53.9%
ANC allows for early detection of PIH
which can prevent the progression to
eclampsia

25 eclamptic
women
25 non pregnant
women

Nwobodo, E. I., Panti, A., & A, N. E. P.
(2012). Adolescent maternal
mortality in North-west Nigeria. West
African Journal of Medicine, 31(4),
224–226.

Review of
hospital case
records

Usmanu Danfodiyo
University Teaching
Hospital (UDUTH),
Sokoto

Case reports of live births for women
15-19 years old were collected and
reviewed. Demographic and other
health data were extracted and
analyzed.

January 2000—
December 2009




2,047 live births
among adolescents

Okafor, U. V, & Ezegwui, H. U.
(2010). Cesarean delivery in
preeclampsia and seasonal variation
in a tropical rainforest belt. Journal
of Postgraduate Medicine, 56(1),
21–23.

University of Nigeria
Teaching Hospital,
Enugu

Retrospective
record review



July 1996—June
2006

Records for patients presenting for CS
with PE/E during rainy and dry seasons
were reviewed, and demographics and
obstetric history and outcome were
extracted and analyzed.

6798 deliveries,
1579 CS deliveries
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Prospective
cohort

University College
Hospital (UCH) and
Adeoyo Maternity
Hospital (AMH),
Ibadan




196 had toxemia of
pregnancy (166: PE
and 30: eclampsia)
Olayemi, O., Strobino, D., Adedapo,
K., Aimakhu, C., Odukogbe, A.-T., &
Salako, B. (2010). Influence of
previous abortions and new
paternity on the risk of hypertension
in nulliparous parturients in Ibadan:



Hypertensi
on in
pregnancy
incidence:
33%

Nulliparous women were recruited
before 20 weeks gestation. For the
baseline data, participants were
interviewed about: sociobiological
variables, history of previous abortions,
sexual history, and family history of




The primary objective of this study was to
assess whether or not seasonality in a
tropical rainforest belt had an effect on
the presentation of preeclamptics
undergoing cesarean section.
Among preeclampsia, 115 had CS during
rainy season, 52 during dry season.
Among those with eclampsia, 26
presented during rainy season and 4
during dry season
This study found a “systemic seasonal
variability in the need for cesarean
delivery for preeclamptics with a peak
during the rainy season”
At AMH, 76.5% of the participants
reported a prior abortion, but only 20.4%
reported same paternity abortion
At UCH, 64.9% reported prior abortion,
and 31.5% reported same paternity
abortion
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a cohort study. The Journal of
Obstetrics and Gynaecology
Research, 36(5), 965–969.
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hypertension and BP and urine protein
were also measured.
Within 48 hours of delivering the final
interview was conducted, BP measured
and urine tested.










Olayemi, O., Strobino, D., Aimakhu,
C., Adedapo, K., Kehinde, A.,
Odukogbe, A.-T., & Salako, B.
(2010). Influence of duration of
sexual cohabitation on the risk of
hypertension in nulliparous
parturients in Ibadan: A cohort study.
The Australian & New Zealand
Journal of Obstetrics & Gynaecology,
50(1), 40–44.

Prospective
cohort

University College
Hospital (UCH) and
Adeoyo Maternity
Hospital (AMH), and
Oluyoro Catholic
Hospital (OCHH),
Ibadan
AMH: 900 women
UCH: 950 women
OCH: 780

Gestational
hypertensi
on
incidence:
28.93%
PE
incidence
4.13%

Nulliparous women were recruited
before 20 weeks gestation. For the
baseline data, participants were
interviewed about: sociobiological
variables, history of previous abortions,
sexual history, and family history of
hypertension and BP and urine protein
were also measured.
Within 48 hours of delivering the final
interview was conducted, BP measured
and urine tested.








Olusanya, B. O. (2011). Perinatal
outcomes of multiple births in
southwest Nigeria. Journal of Health,

48

Retrospective
cross-sectional
review of

Island Maternity
Hospital, Lagos

Participants were included in this study
from a prospectively recruited cohort of



“There was no statistical difference in the
incidence of hypertension among
participants with previous abortion (32.98
vs 33.10 P=0.962)”
Nor was there a statistical difference in
the development of hypertension
regarding change in paternity; 30.12% of
women reporting same paternity
abortions and 34.10% without same
paternity abortions developed
hypertension (p=0.164)
The authors suggest researching
presentation of human leukocyte antigen
(HLA) from semen prior to conception to
reduce incidence of eclampsia.
29.64% reported having had previous
abortion, and 25.92% were same
paternity abortions
This study found that incidence of
hypertension was higher among those
who had had abortions (29.40%) than
those who had not (28.52%)
Change in paternity did not have a
significant impact on incidence of
hypertension
Multivariate analysis found that length of
sexual cohabitation was protective
against hypertension (4% decline in risk of
developing hypertension for every month
increase in cohabitation).
This multivariate model controlling for
age, BMI, educational attainment and
family history of hypertension found that
same paternity abortions were protective
(HR 0.46, CI 0.22—0.96) but previous
abortion alone was not.
The early timing of previous abortions
(first trimester) would account for no
observe protective feature of abortions in
this study (when other studies have
shown abortions to be protective
This study’s primary objective was
determine perinatal outcomes that may
influence neurodevelopment adversely
among multiple gestations; the relevance
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newborns under a separate program on
universal newborn hearing screening.
This study defined “hypertensive
disorders” as pre-eclampsia, eclampsia
and pregnancy-induced hypertension





Onah, H. (2002). Prognostic value of
absolute versus relative rise of blood
pressure in pregnancy. African
Journal of Reproductive Health, 6(1),
32–40.

Department of
Obstetrics and
Gynaecology,
University of Nigeria
Teaching Hospital,
Enugu
cohort

December 17,
1997—March 31,
1999
515 women (7%
incomplete: 478
participants)

Longitudinal measurement of BP,
anthropometric data and MMR in study
population (heathy ANC subjects).
Participants were recruited prior to 16
weeks gestation. Fundal height, weight,
height, BP, and presence or absence of
proteinuria were recorded



Participants were categorized into
groups:
A: relative diastolic blood pressure
(DBP) rise from the averaged 16-20
weeks readings until delivery <
15mmHg and absolute DBP<90mmHg
B: relative DBP rise > 15mmHg and
absolute DBP < 90mmHg






C: absolute DBP> 90mmHg no matter
the relative rise in BP
Analysis was also done with groups
based on systolic BP (using 140mmHg
as the threshold rate and 30mmHg as
the relative rise amount)
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for our study is that Olusanya’s study
indicated that multiple gestation is
associated with an increased risk of
hypertensive disorders.
This study found that mothers with
multiple gestations (twins or triplets in
this case, no higher-order births occurred
during the study period) were significantly
more likely to have had hypertensive
disorders.
268/4,416 (6%) of singleton births were
associated with hypertensive disorders
compared to: 26/157 (16.5%) multiple
gestations

478 of the 515 women completed the
study.
Diagnosing hypertension from a relative
rise in DBP of 15mmHg included 48% of
subjects who had normal pregnancies.
These relative rises in BP could indicate
that closer surveillance is required.
This study found that maternal and fetal
outcomes were not significantly affected
by the relative rise in DBP (as long as DBP
<90mmHg)
Strict eligibility criteria meant many were
excluded (women booked after 16 weeks,
delivered preterm, etc)
The data in this study suggest that
absolute blood pressure (140/90 mmHg)
is a better predictor of feto-maternal
outcome than relative rise measurements
in systolic or diastolic pressures.
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Osungbade, K., Oginni, S., Olumide,
A., K, O., Oginni, S., & Olumide, A.
(2008). Content of antenatal care
services in secondary health care
facilities in Nigeria: implication for
quality of maternal health care.
INTERNATIONAL JOURNAL FOR
QUALITY IN HEALTH CARE, 20(5),
346–351.

Owolabi, A., AO, F., Kuti, O., Adeyemi,
A., Faturoti, S., & Obiajuwa, P.
(2008). Maternal complications and
perinatal outcomes in booked and
unbooked Nigerian mothers.
Singapore Medical Journal, 49(7),
526–531.

Osun state
Cross-sectional

N/A
390 ANC clients

Prospective
case control

Wesley Guild
Hospital Unit, Ilesa,
Nigeria (Obafemi
Awolowo University
Teaching Hospitals
Complex)

Antenatal care exit interview forms from
the Safe Motherhood Needs
Assessment package was used to
collect information from 390 pregnant
women leaving ANC visits.






Outcomes of pregnancies booked for
ANC were compared to outcomes of
women who were unbooked

August 2004—May
2006



1,154 deliveries

Salako, B. L., Olayemi, O., Odukogbe,
A.-T. A., Adedapo, K. S., Aimakhu, C.
O., Alu, F. E., & Ola, B. (2003).
Microalbuminuria in pregnancy as a
predictor of preeclampsia and
eclampsia. West African Journal of
Medicine, 22(4), 295–300.
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Cohort

University College
Hospital (UCH)
Ibadan
93 healthy
normotensive
pregnant women (

During initial booking, BP and urinalysis
was conducted and 100 women who
were normotensive were recruited and
had urinalysis completed.
PE: BP of 140/90 mmHg or more or a
rise of 30mmHg in systolic BP or
15mmHg in diastolic BP (measured two
times, six hours apart, at rest)
associated with proteinuria.







All of the women in this study had their
blood pressure checked which is an
important screening tool for detecting
hypertension and toxaemia (now called
PE)
At the hospitals, 48.6% of the 284 women
and 28.3% of 106 at Health Centers had
their urine checked for protein levels
This study concluded that the screening
services and care were reasonably
capable of addressing pre-eclampsia and
early detection of some fetal problems but
they were insufficient for detecting longstanding pre-eclampsia and other
conditions (detecting and treating severe
anemia and preventing complications of
malaria in pregnancy).
29% (n=336) were unbooked
Unbooked mothers were more likely to be
younger, unmarried, have lower education
and social status, higher proportion of
multipara, experience antepartum
haemorrhage, anemia and PE/E
7.9% of unbooked women developed
PE/E compared to 2.1% of booked
mothers (OR 1.71, 1.15—2.55)
Ninety-three delivered at UCH, two had
spontaneous abortion and five delivered
elsewhere.
At booking 61.3% (57 patients) had
normal albumin excretion and 22 (23.7%)
had microalbuminuria and 12 (15%) had
gross microalbuminuria.
This study found that there was a
statistically significant difference in
incidence of PE with an increase in
albumin excretion.
Microabuminuria was found to predict
preeclampsia with high sensitivity but with
low positive predictive value
(overestimated the number of cases)
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Salako, B., Odukogbe, A., Olayemi,
O., Adedapo, K., & Aimakhu, C.
(2003). Serum albumin, creatinine,
uric acid and hypertensive disorders
of pregnancy. East African Medical
Journal, 80(8), 424–428.

59 women were recruited into the study
when they booked for ANC prior to 20
weeks gestation at the facility and were
included in analysis if they delivered at
the facility as well. These women were
followed throughout their pregnancies.

University College
Hospital (UCH)
Ibadan
Cohort

23 healthy
normotensive
primigravidae
singleton pregnant
women






All participants gave complete clinical
history, had BP measured and urinalysis
done.
Analysis of serum samples was
performed as well (at a lab)





Vanderjagt DJ, Patel RJ, El-Nafaty
AU, Melah GS, Crossey MJ, Glew RH.
High-density lipoprotein and
homocysteine levels correlate
inversely in preeclamptic women in
northern Nigeria. Acta Obstet
Gynecol Scand. Denmark; 2004
Jun;83(6):536–42.
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Federal Medical
Center or the
Specialist Hospital,
Gombe
Case control

June—August 2001
43 cases with PE/E
130 controls

N/A

Participants were recruited while
attending the facilities. The cases were
diagnosed with PE/E if they had systolic
BP greater than 140 mmHg, diastolic BP
greater than 90mmHg, proteinuria in
excess 190 mg total protein/g
creatinine, and edema. Blood samples
were taken from all participants and
serum cholesterol concentration, serum
HDL-cholesterol concentration, and
serum triacylglycerol concentration were
measured.







Of the 59 women recruited, two had
abortions, 13 did not attend the minimum
required number of prenatal clinic visits
and 21 did not deliver at UCH.
23 completed the study; five (21.7%) had
PE, two (8.7%) had pregnancy-induced
hypertension and 16 (69.6%) remained
normotensive.
Oedema and proteinuria were mild in all
cases of PE, one of the cases of PE died.
This study found that there was no
significant difference in uric acid and
creatinine levels between the groups, but
mean serum albumin concentration was
significantly higher in the PE group.
Based on the findings of this study: serum
uric acid and creatinine concentrations
early in pregnancy are not useful to
predict subsequent development of PE/E
Mean serum albumin levels early in
pregnancy could be useful in predicting
subsequent PE—further research is
needed. To define the value of estimation.
Mean serum total homocysteine
concentration was greater among the
women with PE/E than compared to the
controls.
HDL-cholesterol concentration was found
to be higher among the healthy women vs.
those with PE/E
There was not a difference between the
two groups for LDL-cholesterol and
triacylglycerols.
Conclusion: this study found a significant
negative correlation between the level
homocysteine and the concentration of
HDL-cholesterol in women with PE/E in
northern Nigeria
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ADEBAMI, O. J., OYEDEJI, G. A., OWA, J. A., &
OYELAMI, O. A. (2007). Maternal factors in the
etiology of fetal malnutrition in Nigeria.
Pediatrics International, 49(2), 150–155.

Prospective

Neonatal and
Maternity Units of the
Wesley Guild Hospital
Ilesa, Nigeria, a unit
of Obafemi Awolowo
University Teaching
Hospitals Complex,
Ile-Ife
January – August
2001

Maternal prenatal records were
reviewed, additional history
collected from mother. Babies were
classified into ‘babies with FM’ and
‘babies without FM’ and the two
groups were compared.





473 consecutive,
singleton, live birth,
term (37-42 weeks
gestation) neonates”



Adekanle, D., & Akinbile, T. (2012).
Eclampsia and Pregnancy Outcome at
Lautech Teaching Hospital, Osogbo,
SouthWest, Nigeria. Clinics in Mother
and Child Health, 9(1).

Descriptive,
crosssectional
retrospective
review

Ladoke Akintola
University of
Technology Teaching
Hospital, Osogbo,
South West, Nigeria
January 1, 2005—
December 31, 2010

Review of case notes of women
who had eclampsia
Eclampsia defined as: “systolic
blood pressure of > 140mmHg,
diastolic blood pressure of 90
mmHg, proteinuria of at least 1
plus and convulsions in patients
with no background history of
seizure disorder were retrieved.
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The study found that 27% of babies with FM were
born to mothers with PIH/eclampsia compared to
3.6% of babies without FM from mothers with
PIH/eclampsia
“Hypertension and pre-eclampsia induce fibrinoid
degeneration of arteriolar media with resultant
intimal thickening and decreased luminal diameter.
It causes permeability of essential nutrient across
the placental barrier to the fetal and has, therefore,
been implicated as a causative factor of FM”

MMR was 1,981 per 100,000 live births
83 cases of eclampsia of 3952 deliveries,
incidence = 2.1%, CFR: 8.3
Eclampsia accounted for 9.9% of maternal deaths
(n=7)
Almost half of referrals (48.2%) were from private
health facilitates and 2.4% were from TBAs
54.2% had antepartum eclampsia, intrapartum and
postpartum eclamptic were each 22.9%
48.2% were booked in private health facilities and
21.7 were booked in primary health facilities and
then referred to this tertiary center.
71.1% of the cases were treated with MgSO4 and
experienced CFR of 8.3%
Most common maternal morbidity recorded was
acute renal failure
54.2% of patients had caesarean section which
was significantly associated with neonatal survival
Documented improvements in maternal and
neonatal outcome due to use of MgSO4 rather
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Adeyemo, W. L., Rabiu, K. A., Okoturo, T.
M., Adebanjo, A. A., Adewunmi, A. A., &
Adeyemi, M. O. (2012). Orofacial injuries
associated with eclampsia in patients
presenting at a Nigerian Tertiary
Hospital. Journal of Obstetrics and
Gynaecology, January 20(32), 54–57.

Alhassan, M., Anyiam, C., Bosan, I.,
Danbauchi, S., David, S., & Isa, M.
(2008). Role of pre-eclamptic toxaemia
or eclampsia in hypertensive women
attending cardiac clinic of Ahmadu Bello
University Teaching Hospital Zaria,
Nigeria. Annals of African Medicine,
7(3), 133–137.

Faponle, A., & Makinde, O. (2007).
Caesarean section: Intra-operative blood
loss and its restitution. East African
Medical Journal, 84(1), 31–34.

Lagos State
University Teaching
Hospital
Prospective
case review

December 2008—
November 2009
107 patients
presented with
eclampsia

Crosssectional

Cardiac Clinic of
Ahmadu Bello
University Teaching
Hospital, Zaria,
Nigeria
50 consecutive adult
female hypertensive
patients
Obafemi Awolowo
University Teaching
Hospitals Complex,
Ile-Ife, Nigeria

Prospective
study

January 1, 2005—
December 2005
641 patients who
underwent caesarean
section

Geidam, A. D., Audu, B. M., Kawuwa, B. M., &
Obed, J. Y. (2009). Rising trend and indications
of caesarean section at the university of
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Retrospective
review

University of
Maiduguri Teaching
Hospital

For women arriving at the facility
with eclampsia, a proforma was
designed to collect: age, parity,
history of ANC, # of eclamptic fits,
presence/absence of orofacial
injuries and morbidity/mortality
associated with eclampsia. In
cases of orofacial injury, further
details were collected as to the
nature and cause of the injury








all patients provided demographic
and clinical characterization from
history and physical examination
49 of the 50 patients recruited
were studied.




than diazepam, unavailability of MgSO4 supplies—
often due to cost—is likely a contributor to poor
outcome
45 patients (42%) with eclampsia presented with
orofacial injuries. Injuries were most often on the
tongue and/or lips
Injury in most cases (n=16) was caused by
relatives forcing hard objects into patient’s mouth
or biting down during convulsions.
Six patients were injured due to a fall.
98% were not booked for ANC at this facility and
were only referred after developing eclampsia
Patients who received ANC from TBAs and at
churches were significantly more likely to have
orofacial injuries
Those who had PE in a previous pregnancy
developed hypertension an average of 8.42 + 7.69
years after the pregnancy and for those without PE,
12.76 + 8.90 years. (no statistically significant
difference)
Of the 49 participants, 32.7% had previous PE
Of those who had previous PE, 43.8% had
complications of hypertension including:
hypertensive heart disease, hypertensive heart
failure, cerebrovascular accident, and peripartum
cardiac failure.

The following was collected for all
caesarean sections at the facility
during the study period:
Demographics, American Society of
Anaesthesiologists grading,
coexisting conditions, presence of
clinical anaemia, indication for
Caesarean section, pre-operative
packed cell volume, surgical
details.



Retrospective analysis of
caesarean sections performed.





PE/E were cited as indication for 9.4% (n=60) of
the caesarean sections
Pre-eclampsia “carried the expected increased
transfusion and major blood loss risk”

1,192 caesarean sections were performed during
the study period, 79.4% of which were emergency
C/S
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Maiduguri teaching hospital, Nigeria. Annals of
African Medicine, 8(2), 127–132.
http://doi.org/10.4103/1596-3519.56242

Igwegbe, A., & Udigwe, G. (2001). Teenage
pregnancy: still an obstetric risk. Journal of
Obstetrics and Gynaecology, 21(5), 478–481.

January 2000 to
December 2005



Eclampsia caused 7.2% and severe pregnancyinduced hypertension caused 4.8%




32 teenage deliveries, 21.8 per 1000 deliveries
This study found no significant difference between
the teenagers and the control group with regard to
PE/E


1)

Each patient was categorized into three categories:
12 cases Severe PE: hypertension after 20th week,
dBP>110mmHg on admission, proteinuria
>30mg/dl in random urine specimen or > 300mg
in 24hr
10 cases Imminent eclampsia: all parameters in
(1) plus headache, blurring of vision and upper
abdominal pain
12 cases Eclampsia: all parameters in (1) and
seizures.
Six (17.6%) of the cases developed HELLP
syndrome. 4 had eclampsia, 1 had imminent
eclampsia and 1 had pre-eclampsia
CFR: 11.8% The only fatalities were the four
eclamptic patients who also had HELLP syndrome.
There were 38 infants delivered, and six (15.8%)
perinatal deaths.
21 of the 173 cases (12.1%) sustained orofacial
injuries (mostly lacerations and bruises to soft
tissues including the tongue). Dislocation of the
lower jaw (temporomandibular joint dislocation)
occurred in one case. Two patients died due to
complications related to uncontrolled bleeding,
acute renal failure and septicemia.
“antibiotics were prescribed in all the cases as part
of the treatment regimen for eclampsia”
Recommend a campaign to ensure ANC
attendance and against the forceful insertion of
unpadded objects into the mouth during seizure.

10,097 deliveries
Retrospective
and
comparative
study

Nnamdi Azikiwe
University Teaching
Hospital, Nnewi.
June 1 1995—
November 31, 1997

Reviewed hospital records of 28
teenage deliveries and 30 records
of mothers aged 20-24 were
randomly selected to be used as
controls

1465 deliveries

Makinde, O. N., Adegoke, O. A., Adediran, I. A.,
Ndububa, D. A., Adeyemi, A. B., Owolabi, A. T.,
… Salawu, L. (2009). HELLP syndrome: the
experience at Ile-Ife, Nigeria. Journal of
Obstetrics and Gynaecology : The Journal of the
Institute of Obstetrics and Gynaecology, 29(3),
195–199.
http://doi.org/10.1080/0144361090275394
5

Ndukwe, K., Ugboko, V., Ogunlola, I., Orji, E., &
Makinde, O. (2004). Orofacial injuries in
eclamptic Nigerians. African Journal of
Reproductive Health, 8(3), 147–151.

(cohort)

Obafemi Awolowo
University Teaching
Hospitals Complex,
Ile-Ife, Nigeria
January 1—December
31, 2006
34 consecutive cases
of severe PE/E

Retrospective
case review

Department of
Obstetrics and
Gynaecology Obafemi
Awolowo University
Teaching Hospital,
Ile-Ife, Nigeria
January 1994 to July
2002
173 patient records

54

Cases of severe PE/E were
recruited and bloodwork and other
biochecmical studies done (platelet
count, peripheral blood smear,
serum bilirubin lactate
dehydrogenase, and aspartate
transaminases estimation)
HELLP syndrome was diagnosed in
those who developed: haemolysis,
abnormal liver function and
thrombocytopenia (platelet count
<90,000mm3) were

2)
3)





Cases from patients with eclampsia
during the study period were
identified, and data extracted and
analyzed.
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Okafor, U., & Efetie, E. (2006). Cerebrovascular
accident with quadriplegia following
postpartum eclampsia. ACTA
ANAESTHESIOLOGICA SCANDINAVICA

Case report

National Hospital,
Abuja
One, 26 –year-old
woman

The patient diagnosed with
postpartum eclampsia was referred
from a peripheral hospital, she
delivered a live baby vaginally and
experienced a tonic/clonic seizure
just after delivering and became
unconscious.
After seizing, her Glasgow Coma
score was determined to be 3,
meaning she was deeply
unconscious.
She had a fever (38˚C), mild pedal
oedema, puffy eyes and ‘grunting
respiration,” a BP of 130/80
mmHg on presentation.









University of Nigeria
Teaching Hospital
(UNTH), Enugu.
Okafor, U., & Efetie, E. (2009). Anaesthetic
management of patients with preeclampsia/eclampsia and perinatal outcome.
Journal of Maternal- Fetal and Neonatal
Medicine, 22(8), 688–692.

Retrospective
record review

July 1998—June
2008
6798 total deliveries,
285 cases PE/E,
196 cases of PE/E
delivered by CS


Hospital records for patients with
PE/E who had caesarean delivery
were reviewed and demographics,
obstetric outcomes, and type of
anaesthesia administered was
recorded and analyzed.
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There had been no history of elevated BP during
ANC.
Her case was managed with magnesium sulphate,
IV 5% dextrose/salinje, 50% dextrose and Zinacef
(antibiotic).
She remained in the ICU for 42 days and was
discharged from the Hospital after 169 days. BP
had normalized, but she was still quadriplegic.
This is the only known case of quadriplegia
resulting from postpartum eclampsia in subSaharan Africa.
This study reinforced the thought that neurological
effects of PE/E are more common when eclampsia
presents postpartum; this patient had cerebral
oedema

12.4% (n=196) of all CS were for patients with
PE/E. (59: mild PE, 107: severe PE, 30: eclampsia)
This group experienced 38 perinatal deaths, 180
per 1000 births (19 stillbirths and 19 early
neonatal deaths).
157 were delivered under general anaesthesia; 34
under spinal anaesthesia and 5 under epidural
block.
79% of the perinatal deaths were delivered by
general anaesthesia.
Indications for CS among PE/E patients included:
severe PE/E with unfavorable cervix, fetal
distress/intrauterine growth retardation, previous
CS, failed induction/failed vacuum extraction,
prolonged labor and others
25.6% of perinatal deaths occurred in cases of
severe PE, 21.2% occurred in cases of eclampsia
and only 4.9% occurred in cases of PE.
89% of neonatal deaths occurred <36 weeks; 52%
were <32 weeks
The increase to 20% use of regional anaesthesia
(vs 1.3% in an earlier study) did not seem to have
an impact on perinatal death.
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Okafor, U., & Okezie, O. (2005). Maternal and
fetal outcome of anaesthesia of caesarean
delivery in preeclampsia / eclampsia in Enugu,
Nigeria: a retrospective observational study.
International Journal of Obstetric Anesthesia,
14(2), 108–113.

University of Nigeria
Teaching Hospital
(UNTH), Enugu.
Retrospective
survey of
hospital
records



July 1998—June
2002

176 of 3926 (4.5%) deliveries were
complicated by PE/E

3926 total deliveries,

CFR: 5.2%




898 CS deliveries


125 cases of PE/E
delivered by CS




Oladapo, OT, JO Sotunsa, and AO Sule-Odu.
“The Rise in Caesarean Birth Rate in Sagamu,
Nigeria: Reflection of Changes in Obstetric
Practice.” Journal of Obstetrics and
Gynaecology 24.4 (2004): 377–381.

Olabisi Onabanjo
University Teaching
Hospital, Sagamu
Retrospective
comparative
study

Two periods:
January 1, 1989—
December 31, 1991


Data were collected from theatre
records, labor ward records, and
case files on deliveries during the
two study periods.




July 1, 2000—June
30, 2003

OLADAPO, O. T., ADEKANLE, D. A., &
DUROJAIYE, B. O. (2007). Maternal risk factors
associated with fetal death during antenatal
care in low-resource tertiary hospitals.
Australian and New Zealand Journal of
Obstetrics and Gynaecology, 47(5), 383–388.

Case control
study

Olabisi Onabanjo
University Teaching
Hospital, Sagamu,
Ogun State (OOUTH)
and Ladoke Akintola
University of
Technology Teaching
Hospital, Osogbo,
Osun state
(LAUTECHTH)
January 1, 2002 and
December 31, 2006
at OOUTH
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Cases: booked singleton
pregnancies who experienced fetal
death during ANC



Controls: booked pregnancies who
had live births
Four controls selected for each
case (two immediately before and
two after each case).
Cases and controls were
compared.







This facility was using methyldopa to control
hypertension in these patients and nifedipine and
beta-blockers added at the physicians’ advice.
Hydralazine was also used to manage hypertensive
crises.
Due to cost and unavailability of MgSO4, diazepam
is often used prophylactically and also to treat
eclamptic fits
82.4% (n=103) of the cases of PE/E delivered by
CS were emergency procedures.
Six maternal deaths all of whom received general
anaesthesia.
General anaesthesia was used for 116 (92.8%) of
the patients, spinal anaesthesia was used in the
other nine cases.
13 stillbirths and 10 neonatal deaths
Recommend using spinal anaesthesia for better
health outcomes and also reduced cost.
This study found that hypertensive disorders in
pregnancy (severe PE/E) was cited as the
indication for CS in 20 (8.9%) of caesareans during
from 1989—1991
This increased to 13.4% (n=44) of CS due to
severe PE/E in 2000-2003.
This finding is in line with other papers that report
better maternal and fetal outcomes when a woman
with severe PE/E is delivered via caesarean.

After multivariate logistic regression analyses, the
following were found as predictors for fetal death
among women receiving ANC: pregnancy induced
hypertension (adjusted OR: 8.24, CI 3.01—22.51),
proteinuria (adj. OR 4.23, CI: 1.57—11.42) and
perceived reduction of fetal movements (adj OR
7.17, CI: 1.57—45.76).
% of cases and controls with:
proteinuria: Cases: 41.9%, controls, 11.0%
PIH: cases: 43.5%, controls: 7.6%
previous hypertension: cases: 10.9%, controls:
2.2%
PE: cases 24.4%, controls: 0.0%
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January 1, 2003—
December 31, 2006
LAUTECHTH
Cases: 46
Controls: 184

Olagbuji, B., Ezeanochie, M., Ande, A., &
Okonkwo, C. (2012). Prevalence and
risk factors for persistent hypertension
after the puerperium in pregnancies
complicated with hypertensive
disorders. Journal of Obstetrics and
Gynaecology : The Journal of the
Institute of Obstetrics and Gynaecology,
32(6), 529–532.

Olusanya, B. O., & Solanke, O. A. (2012).
Perinatal outcomes associated with maternal
hypertensive disorders of pregnancy in a
developing country. Hypertension in Pregnancy,
31(1), 120–130.

Prospective
cohort study

University of Benin
Teaching Hospital
(UBTH), Benin City,
Nigeria
December 2009—
November 2010.
198 women

Island Maternity
Hospital (IMH), Lagos
Retrospective
study

May 15, 2005—2007

Women who were managed for
new-onset gestational hypertensive
disorders who had received ANC,
intrapartum and postpartum care
at the facility were recruited during
the prenatal period.
“new-onset gestational
hypertensive disorders” =
gestational hypertension, or PE/E
after 20 weeks gestation in
previously normotensive, nonproteinuric women with no history
of chronic hypertension.
Mothers with HDP were recruited
and their cases reviewed for: fetal
distress, prematurity (<37 weeks
gestation), low birth weight
(<2500g), fetal growth restriction,
birth asphyxia, admission to special
baby care unit, and lack of
exclusive breastfeeding as well as
maternal factors.









216 mothers with
HDP
Hypertensive disorders of
pregnancy (HDP): chronic
hypertension, pregnancy-induced
hypertension, pre-eclampsia and
eclampsia
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“Persistent hypertension” was diagnosed if
hypertension remained during the postpartum visit,
six weeks after delivery.
51 (25.8%) were discovered to have persistent
hypertension at the 6th week postnatal follow up
visit.
Persistent hypertension was significantly higher
among women with maternal age > 35 years old
and also among HIV-positive women.
Serum uric acid and creatinine levels were also
significantly higher among the women who
developed persistent hypertension

216 HDP/ 3491 mother-infant pairs = 6.2%
incidence of HDP
10 (4.6%) were chronic hypertension, 120 (55.6%):
pregnancy-induced hypertension, 86 (39.8%): PE/E
After adjusting for maternal factors and some
relevant infant confounders, this study saw that
HDP increased the odds of preterm birth (OR 3.30),
fetal growth restriction (OR 2.94), low birth weight
(OR 4.68) and birth asphyxia (OR 2.99).
Recommends greater collaboration between
obstetricians and pediatricians to address HDP and
its effects beyond maternal and perinatal mortality.
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Olusanya, B. O., & Solanke, O. A. (2012).
Maternal and neonatal profile of late-preterm
survivors in a poorly resourced country. The
Journal of Maternal-Fetal & Neonatal Medicine,
25(4), 346–352.

Island Maternity
Hospital, Lagos
Crosssectional
study

May 2005—
December 2007
4176 Surviving late
preterm and full-term
live births

Infants were recruited under 24
hours after birth, before being
discharged from the hospital.



Late preterm was defined as: 340/7
to 366/7 weeks gestation.



Gestational age was based on
number of days between LMP (last
menstrual period) and delivery






University of Benin
Teaching Hospital

Onuh, S., & Aisien, A. (2004). Maternal and
fetal outcome in eclamptic patients in Benin
City, Nigeria. Journal of Obstetrics and
Gynaecology, 24(7), 765–768.

1995—2002
103 cases of
eclampsia


Patient data for cases of eclampsia
was retrieved from case notes and
summary sheets and analyzed.





Onyearugha, C. N., & Ugboma, H. A. A. (2012).
Fetal outcome of antepartum and intrapartum
eclampsia in Aba, southeastern Nigeria.
Tropical Doctor, 42(3), 129–132.

Retrospective
review of
hospital
registers

Department of
Obstetrics and
Gynaecology, Abia
State University
Teaching Hospital,
Abia
January 1, 2002—
December 31, 2007
48 babies delivered
to eclamptic mothers
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Relevant information (gestational
age, birthweight five-minute Apgar
score and mother’s age, booking
status parity, number of fits and
mode of delivery) was obtained
from delivery registers for 48
babies delivered to eclamptic
mothers; data analyzed.






89 (38.4% of women with hypertensive disorders:
PE/E and PIH) had PE/E and 41 (46.1%) of them
were late-preterm
Univariate analysis showed that having a
hypertensive disorder was significantly associated
with late-preterm delivery
Multivariate analysis revealed that late-preterm
delivery was independently associated with
hypertensive disorders (OR 3.66, CI 1.97—6.84).
Incidence of eclampsia: 1.32%; The incidence of
eclampsia among nullipara was 2.4% which is
significantly higher than the incidence among
multipara (0.9%). CFR: 11.7%
Only 13, (12.6%) of the patients came for ANC at
UBTH while 90 (87.4%) either were referred from
other facilities or did not attend ANC (“unbooked”)
58.4% (n=59) of the patients were delivered by
caesarean section.
Complications included: cerebrovascular accident
(n=6), transient blindness (n=6), abruptio
placentae (n=6), HELLP syndrome (n=4), Acute
renal failure (n=3), disseminated intravascular
coagulation (n=2), aspiration pneumonia (n=1);
26.2% of cases experienced a complication
Fetal outcome: there were 117 births (14 sets of
twins, and 1 set of triplets); 25 perinatal deaths (9
stillbirths, and 16 early neonatal deaths)
prematurity was the cause of death for 17 (68%)
and birth asphyxia 6 (24%) and sepsis 2 (8%).
Hospital incidence of eclampsia- 0.80%; CFR:
20.8%
Women only come to this facility for treatment as a
last resort; tradition treatment for fitting is “crude
oil pushed into their mouths and eyes”
13 babies were <1500g, 15 were 1500g-2499g,
19 were 2500g—4000g, and 1 was >4000g
Five-minute Apgar sore: 29 (60%)= 0 [stillborn], 4
(8.3%)= 1-3 [severely asphyxiated], 9 (18.8%)= 46, 6 (12.5%) >7
Poor Apgar scores could be partly explained by
asphyxiogenic effect in utero during maternal
convulsions.
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University of Benin
Teaching Hospital
(UBTH)

Onyiriuka, A. N., & Okolo, A. A. (2007). Neonatal
morbidity pattern in infants born in Benin City
to Nigerian mothers with hypertensive
disorders in pregnancy. Nigerian Journal of
Clinical Practice, 10(4), 294–299.

January 1, 1992—
June 30, 1994
Case control
study

Cases: 256 live
newborns of
hypertensive mothers

Controls: 804 infants
of normotensive
mothers

Osinubi, A., Ajayi, G., & Adegbola, O. (2009).
Effect of normal and pre-eclamptic pregnancies
on plasma cholinesterase in Nigerian women.
African Journal of Endocrinology and
Metabolism, 8(1), 1–3.

Case control
study

Antenatal Clinic and
Prenatal Diagnostic
and Therapy Center,
College of Medicine
of the University of
Lagos/Lagos
University Teaching
Hospital
30 women: mild PE
27 women: severe PE
30: normal
pregnancy
30 healthy nonpregnant women
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For each hypertensive mother
recruited, three normotensive
pregnant mothers were recruited
as controls. All participants came
for clinical visits every 2 weeks and
had BP measured and urine tested
HDP= documented history of
hypertension (140/90 mmHg)
before pregnancy, an increase in
either SBP (by 30mmHg) or DBP (by
15mmHg) above the booking BP,
an intrapartum blood pressure =
140.90 mmHg obtained on at least
two occasions not less than six
hours apart during delivery

Patients were recruited and
categorized into four groups:
healthy non pregnant, healthy
pregnant, mild PE and severe PE
Mild PE: pregnancy-induced sBP
>160mmHg or diastolic BP >
110mmHg with proteinuria 2+
Severe PE: any two of the following
signs were present: (1) systolic
blood pressure >160 mmHg or
diastolic blood pressure >110
mmHg; (2) proteinuria (>3+ on
dipstick [500 mg/dL]); (3) facial
oedema.














Comparing the outcomes of the infants born to
hypertensive vs. normotensive women, this study
found that 39.5% vs 17.9% were low birth weight,
29.3% vs. 12.% were preterm
Caesarean delivery rate was significantly higher
among hypertensive women.
This study concludes that “pregnancies
complicated by hypertension are associated with
an increase in neonatal morbidity” and that these
infants are a high-risk group that need close
attention and treatment of these specific
outcomes.

Plasma cholinesterase concentrations:
Healthy, non-pregnant (controls) 3594 + 422 m/L
Healthy pregnant: 2135 + 330 [postpartum: 3212
+ 346. Mild PE: 1781 +330 [postpartum: 3157 +
75]
Severe PE: 1630 + 326 [postpartum: 2864 + 700]
This study found that pregnancy reduced plasma
cholinesterase concentrations when compared to
healthy non-pregnant women; PE further reduced
concentrations when compared to normal pregnant
women.
Reduced plasma cholinesterase activity leads to
prolonged succinylcholine effect.
It was also noted, that cases of severe PE did not
see concentrations of serum cholinesterase return
to normal within six weeks after delivery.
Recommendations: cases of severe PE should be
monitored beyond six weeks postpartum, consider
using peripheral nerve stimulator when
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Serum cholinesterase
concentrations were measured by
collecting blood and separating the
plasma for cholinesterase assays
between 28—41 weeks for
pregnant women and 6 weeks
postpartum

University of Nigeria
Teaching Hospital,
Enugu

Ozumba, B. C., & Anya, S. E. (2002). Maternal
deaths associated with cesarean section in
Enugu, Nigeria. International Journal of
Gynaecology and Obstetrics: The Official Organ
of the International Federation of Gynaecology
and Obstetrics, 76(3), 307–309.

succinylcholine is administered in PE/E, further
research targeting cholinesterase activity as
diagnostic tool and prognostic marker in PE/E
pregnancies.




January 1994—
December 1999


1,684 cesarean
section deliveries

Waziri-Erameh, M. J., Omoti, a E., & Edema, O.
T. (2003). Bilateral total loss of vision following
eclampsia--a case report. African Journal of
Reproductive Health, 7(2), 106–108.

60

Case report

Benin City

31 year old patient, para-5 who
suffered bi-lateral total loss of
vision for four weeks. She had been
successfully treated for eclampsia
and lost vision during the
convulsion, this progressively
became worse and she was
referred for ophthalmological
consultation





Overall CS rate of 25.6%
Hypertensive disorders of pregnancy (HDP) was
cited as indication for 27% of CS (behind
prolonged/ obstructed labor, 31%).
There were 26 deaths following CS, 23% of which
were associated with HDP

Eclampsia was treated using Hydrallazine to
reduce the blood pressure and diazepam to stop
the convulsions.
Upon referral, she had a blood pressure of 130.90,
which may indicate that she had underlying
hypertension during pregnancy
Steroids were given and within a few weeks, her
vision was restored.
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Abalos, E., Cuesta, C., Grosso, A., Chou, D., &
Say, L. (2013). Global and regional estimates of
preeclampsia and eclampsia: a systematic
review. European Journal of Obstetrics &
Gynecology and Reproductive Biology, 170(1),
1–7.

Systematic Review

11 datasets found on PE/E in Nigeria (4 on PE, 7 on E). Total population covered by these datasets = 54,144
women. Crude incidence of PE among the four datasets = 4.6% and crude incidence of E among the 7 datasets
= 4.0%

Ameh, C., & van den Broek, N. (2015). Making It
Happen: Training health-care providers in
emergency obstetric and newborn care. Best
Practice & Research Clinical Obstetrics &
Gynaecology, 1–15.

The Making It Happen multi-country programme (implemented in Nigeria during Phase II) aims to build the
capacity of health-care providers to recognize and manage complications during pregnancy, childbirth and the
post-partum period through ‘skills-and-drills’ competency-based training in skilled birth attendance, emergency
obstetric care and early newborn care (EmONC).
Program description

Key interventions under MiH programme are:
1) in-service training of healthcare providers working in maternity areas (including management of severe PE/E)
2) quality improvement using audit methodology
3) improved monitoring and evaluation.

Ekele, B. A. (2009). Use of magnesium sulfate to
manage pre-eclampsia and eclampsia in Nigeria:
overcoming the odds. Annals of African
Medicine, 8(2), 73–75.

Editorial

Garba, J., & Umar, S. (2013). etiology of
maternal mortality using verbal autopsy at
Sokoto, North-Western Nigeria. Etiologie de la
mortalité maternelle en utilisant l’autopsie
verbale à Sokoto, Nigeria du Nord-Ouest. African
Journal of Primary Health Care and Family
Medicine, 5(1), 6 p

Descriptive, crosssectional study

Hlimi, T. (2015). Association of anemia, preeclampsia and eclampsia with seasonality: A
realist systematic review. Health & Place, 31(0),

Systematic review
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Even though MgSO4 has been shown to be the safest and most effective method for managing convulsions in
pregnant women and to prevent recurrence, many providers and facilities have been unable to adjust to the new
standard and still stock and use diazepam to manage eclampsia. Other barriers to using MgSO4 include: fear of
toxicity (which is detectable and treatable using calcium gluconate), no local manufacturer making availability
more difficult and more expensive, and the dosage itself.
Interviews using a verbal autopsy questionnaire with relatives of a women 15-49 years old who had died of
pregnancy-related condition in the preceding two years. Sixty-two maternal deaths were identified and 58
questionnaires for the verbal autopsy were completed.
Eclampsia was the cause of death for 18.97% (second most common after Haemorrhage, 48.28%)
Among primipara, eclampsia was the cause of death for 29.2%
Hlimi conducted a systematic literature review of studies that look at the effect of weather/rainfall/seasonality
might have on the development of anemia and PE/E. This review included three studies from Nigeria, one was

Citation

Paper Type

180–192.

Summary
published in 1970, one in 1981 and one in 2009. The study from 2009 (Okafor et al.) is included in this current
literature review on PE/E in Nigeria.

Overall, Hlimi found that there are often observed seasonal patterns for anemia and PE/E and that PE/E might
follow similar seasonal variation to malaria, but more research is needed.

Lalonde, A., & Grellier, R. (2012). FIGO saving
mothers and newborns initiative 2006–2011.
International Journal of Gynecology & Obstetrics.

McDonald, S., Lutsiv, O., Dzaja, N., & Duley, L.
(2012). A systematic review of maternal and
infant outcomes following magnesium sulfate for
pre-eclampsia/eclampsia in real-world use.
International Journal of Gynecology and
Obstetrics, 118, 90–96.

Summary of FIGO
funded projects
under Safe
Motherhood and
Newborn Health
(SMNH) Committee

Systematic review

One of the projects described was implemented in Nigeria: Saving mothers and newborns in Edo, Amambra and
Kaduna States; this project aimed to improve data collection and use, through improved birth register records,
fatal outcome records and clinical audits. The project also trained providers on EmONC and strengthened
capacity of national professional societies (midwifery and obstetric) through development of protocols and
advocacy activities. Three achievements of the project were: supplying MgSO4 to all state hospitals by the
Kaduna state government, reduced cost of MgSO4 by manufacturers and four obstetric protocols were
introduced.
A systematic review of studies conducted looking at the effectiveness of magnesium sulfate. The authors
searched MEDLINE and EMBASE for studies published from January 7, 1990 to July 20, 2010 and included
‘before-and-after’ studies, cohort studies, and serial cross-sectional studies which reported outcomes of women
receiving MgSO4 compared to a group of women who did not. Studies looking at a sample <10 were excluded.
Primary outcomes were: maternal death, infant death, eclampsia or recurrent seizure. Secondary outcomes
included: pulmonary edema, pneumonia, cardiac arrest, coagulopathy, renal failure, liver failure, cerebral
hemorrhage, respiratory depression or arrest, toxicity (calcium gluconate required to stop toxic effect of MgSO4),
length of stay in ICUs. From 754 citations, 156 full text articles were reviewed and 150 were excluded for
sample size, study design or failure to report outcomes of interest.
The six studies included were all cohort studies, included 536 women with eclampsia treated with MgSO4 and
698 who were treated with another anticonvulsant.
The results from the six studies included, seem to indicate that the improvements demonstrated in RCTs are
comparable to those observed in real-world use of MgSO4 and result in reduction in recurrent seizures, morbidity
and mortality.

Mohammed, S., Ahonsi, B., Oginni, A., Tukur, J.,
& Adoyi, G. (2015). Obstetric knowledge of
nurse-educators in Nigeria: Levels, regional
differentials and their implications for maternal
health delivery. Health Education Journal.

Cross-sectional
survey

This paper aimed to assess the knowledge of nurse-midwife educators on the major causes of maternal
mortality in Nigeria by administering a survey. The authors found that 57.2% of 292 educators could diagnose
pre-eclampsia. 86% knew about MgSO4 but only 16.8% knew about using calcium gluconate as an antidote to
MgSO4 toxicity. Nearly two thirds (63.7%) were unable to describe the steps of active management of third stage
labor. In addition to these, other knowledge gaps were identified relating to oxytocic use for hospital delivery,
when to perform episiotomies, and causes of postpartum haemorrhage.
The authors propose scale up of quality obstetric care by updating pre-service curricula in addition to in-service
appraisals and continuing education on these issues.

Okafor, U. (2009). Maternal and perinatal
outcome after caesarean delivery in
preeclampsia or eclampsia in Enugu, Nigeria:
four years on. International Journal of Obstetric
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Correspondence

This correspondence from Okafor provides a brief update on health outcomes following caesarean delivery of
women with PE/E and their babies. Based on a retrospective review of hospital cases of PE/E deliveries via CS
(1998—2002), the author previously recommended a multidisciplinary approach to management and increased

Citation

Paper Type

Anesthesia.

Summary
use of spinal anaesthesia. Here, the author looks at records from July 2002 to June 2006 to assess whether the
outcomes have improved for women with PE/E undergoing CS.
During the recent four year period, three eclamptics (2 spinal, 1 epidural), 17 severe PE (15 spinal, two epidural)
and 10 mild PE (8 spinal, 2 epidural) were delivered via CS.
Maternal outcomes were improved when compared to the prior study period; possibly due to the preference of
spinal anaesthesia (general anaesthesia is known to be associated with higher rates of maternal mortality and
morbidity).
Perinatal mortality was unchanged.
Definitions:
Mild preeclampsia: BP between 140/90 and 160/110 mmHg on two occasions six hours or more apart, or a
rise from midtrimester values of 3mmHg in systolic or 15mmHg in diastolic BP, more than ).3g/L proteinuria on
two consecutive specimens and significant non-dependent oedema.
Severe PE: BP persistently above 160/110 mmHg, proteinuria above 5g/24 hours and headache, blurred vision,
epigastric pain and oliguria.

Okereke, Ekechi, Babatunde Ahonsi, et al.
“Benefits of Using Magnesium Sulphate
(MgSO(4)) for Eclampsia Management and
Maternal Mortality Reduction: Lessons from
Kano State in Northern Nigeria.” BMC research
notes 5 (2012).

Olamijulo, J., Ogedengbe, O., & Giwa-Osagie, O.
(2008). Availability and use of obstetric
guidelines in Nigeria. International Journal of
Gynaecology and Obstetrics, 102(3), 242–245

Osungbade, K., & Ige, O. (2011). Public health
perspectives of preeclampsia in developing
countries: implication for health system
strengthening. Journal of Pregnancy.
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Project description

In 2012, 33 heath workers in five facilities in Jigawa state were selected and recruited to be mentors for junior
medical officers, nurses, midwives, CHOs and CHEWs to improve MNCH service delivery. In February of 2013,
this study conducted interviews with stakeholders (mentors, mentees, facility managers and state government
health officials) to assess perceptions about clinical mentoring as a strategy to improve MNCH service delivery.
The clinical mentors and the healthcare workers in-charge of obstetrics saw changes regarding the introduction
and updating of treatment guidelines for basic emergency health services including using magnesium sulphate
to manage PE/E. This study concludes that clinical mentoring improved worker capacity to deliver quality MNCH
services and that by integrating mentorship into the district health system, it has the potential to promote
government ownership and sustainability.

Cross-sections
survey

This survey was meant to assess the availability and use of obstetric guidelines by asking Ob/Gyns (at SOGON
Annual General Meeting and Scientific Conference) to respond to a self-administered questionnaire. One
hundred and seventy-eight responses were completed, but only 176 were able to be analyzed. Most (83.5%) of
the respondents had over ten years’ experience. The results showed that 55.9% of respondents reported that
guidelines for severe PE/E were in place, but only 38.8% said that they were used regularly.
Literature review of papers published on PE/E in developing countries between 2000 and 2010. Based on the
papers identified that reported numbers for Nigeria, prevalence of PE ranged from 2-16.7%.

Review Article

Challenges identified include: managing PE, three delays to care, health policies.
Recommend: risk assessment and clinical management, society and community interventions, and health
system strengthening

Citation

Tukur, J. (2009). The use of magnesium
sulphate for the treatment of severe preeclampsia and eclampsia. Annals of African
Medicine, 8(2), 76–80.

Paper Type

Summary

Tukur discusses the severity of maternal mortality due to PE/E in Nigeria and describes key issues related to
using magnesium sulphate He explains that while MgSO4 was introduced in 1925 to manage convulsions it
wasn’t until 1995 that its efficacy was confirmed by the Collaborative Eclampsia Trial (Magpie Trial). Despite its
now known efficacy, MgSO4 remains mostly unavailable in developing countries where it is most needed. Tukur
goes on to describe the two predominant dosing regimens: Pritchard and Zuspan as well as the importance of
monitoring for toxicity. Choice of regimen depends on various factors including expertise and availability of staff
to administer the drug, (Pritchard is often preferred in low resource settings because it is a simple IM injection
that can be administered by lower cadre providers and doesn’t require infusion pump).
Literature review

Pritchard involves administering a loading dose bolus of 4g of MgSO4 via IV over 5-10 minutes and is followed
immediately by 10g (5g in each buttock) and subsequent maintenance doses of 5g in alternate buttocks every
four hours.
Zuspan involves an initial IV dose of 4g of MgSO4 over 5-10 minutes followed by 1-2g every hour by infusion
pump(a gravity fed infusion set can be used)
It is necessary to train providers on MgSo4 use and ensure that protocols for its use are in place. Ensuring the
involvement of important stakeholders is essential to ensure availability and utilization of MgSO4

64

Appendix VI:
SUMMARY TABLES OF DESCRIPTIVE PAPERS ON HOSPITAL REPORTS
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Abe, E., & Omo-Aghoja, L. O. (2008). Maternal
mortality at the Central Hospital, Benin City
Nigeria: a ten year review. African Journal of
Reproductive Health, 12(3), 17–26.

Study
Design

Retrospecti
ve review
of hospital
records.

Location, Timeframe, and
Sample size

Prevalence/

Main findings/ limitations

Incidence/
CFR

Conclusions/

Obstetric unit of Central
Hospital, Benin City,
Nigeria
January 1, 1994 –
December 31, 2003

Recommendations=



N/A



28,186 deliveries


Aboyeji, A., Ijaiya, M., & AAFawole. (2007).
Maternal mortality in a Nigerian teaching
hospital -- a continuing tragedy. Tropical Doctor,
37(2), 83–85.

Retrospecti
ve review
of hospital
records.




University of Ilorin Teaching
Hospital, Ilorin, Nigeria
January 1, 1997—
December 31, 2002
13,092 live births



Adamu, A., & Ekele, B. (2012). Pregnancy
outcome in women with eclampsia at a tertiary
centre in northern Nigeria. African Journal of
Gynecology & Obstetrics, 119(S3), S531–S867.
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Retrospecti
ve analysis
of
demograph
ic and
clinical
data of
patients
with
eclampsia

Obstetrics & Gynecology
department of Usmanu
Danfodiyo University
Teaching Hospital.

January 2000—December
2009.

1035 eclamptics




Incidence:
1035/23,26
6 = 4.4%

CFR = 18%









146 maternal deaths over the 10 year period, overall maternal
mortality ratio of 518/100,000 total deliveries.
PE/E was fourth leading direct cause of maternal mortality,
contributing 15.6% of overall maternal deaths.
Training, retraining and continuing medical education on emergency
obstetric care, making maternal health care free, and reducing
poverty and increasing female education to reduce the burden of
maternal mortality.
108 maternal deaths during the period, overall maternal mortality
ratio of 825/100,000 live births
Severe PE/E was most common cause of death (27.8%)
“The emergence of severe pre-eclampsia/eclampsia as the common
most clinical cause of maternal death is not entirely surprising. […] it
is also possible that this is so because more of the patients with the
condition are elderly and they may have other medical conditions such
as hypertension as an underlying disease. This will carry more
mortality than the straightforward eclampsia associated with
primigravidity.”
MMR may be overestimated since this is a referral center and often
sees complicated, high risk cases.
Recommendations: train TBAs to recognize obstetric emergencies,
Maternal mortality Ratio = 2670/100,000; 26.7% of which were
eclamptic deaths.
Intrapartum: 62.6%
Delivery method: spontaneous vaginal= 45.2%; instrumental
deliveries= 28.7%, destructive operations= 6.5%, Caesarean section
was performed in 19.6% of the cases, 6.1% of eclamptic women died
undelivered.
Women were more likely to die if they had not received antenatal care.
Complications among women who died included: Aspiration
pneumonitis, pulmonary edema, hyperpyrexia, cerebral edema, acute
renal failure, disseminated intravascular coagulopathy, abruption
placentae, HELLP syndrome, and anesthetic complication
Over half of the maternal deaths occurred in the first 24 hours after
hospital admission.
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Adamu, Y. M., Salihu, H. M., Sathiakumar, N., &
Alexander, G. R. (2003). Maternal mortality in
northern Nigeria: a population-based study.
European Journal of Obstetrics and Gynecology
and Reproductive Biology, 109(2), 153–159.


Retrospecti
ve on vital
statistics
register

Kano State, Research and
Statistics Department of
the Ministry of Health in
Kano State

Eclampsia
causes
31.3% of all
maternal
deaths





Adelaja, L. M., & Olufemi Taiwo, O. (2011).
Maternal and fetal outcome of obstetric
emergencies in a tertiary health institution in
South-Western Nigeria. ISRN Obstetrics and
Gynecology, 2011.

Ade-Ojo, I., & Loto, O. (2008). Outcome of
eclampsia at the Obafemi Awolowo University
Teaching Hospital Complex, Ile-Ife. Nigerian
Journal of Clinical Practice, 11(3), 279–284.

Retrospecti
ve study of
case
records

Olabisi Onabanjo University
Teaching Hospital
(OOUTH), Sagamu, Nigeria
Jan 2005—December
2007
262 obstetric emergencies
out of1420 deliveries

Rerospecti
ve review
of case
records

Obafemi Awolowo
University Teachin Hospital
Complex, Ile-Ife, Nigeria
January 1, 1994—
December 31, 2003

Severe PIH:
8.8% of
obstetric
emergencie
s




Obstetric emergencies accounted for 70.6 of the 17 maternal deaths
Prevention and effective management through ANC, personal financial
planning for pregnancy, development of adequate blood banking
system, regular training of doctors and nurses can go a long way to
reduce maternal and perinatal mortality in Nigeria.



Eclampsia was highest among young adults <25 years of age, those
women carrying their first pregnancy, those who were unbooked.
62.5% of cases occurred after 36 weeks gestation
Common symptoms included: headache (100%), hypertension (75%)
and fever (20.2%)
Antepartum eclampsia (56.5%)
Maternal mortality = 8.0% and Perinatal mortality = 19.1%
Morbidities include: acute renal failure, pulmonary edema, and
aspiration pneumonitis
55.3% (n=69) had emergency abdominal delivery
Recommendations include: strengthening essential obstetric care

Eclampsia:
8.0% of
obstetric
emergencie
s

Incidence of
elcampsia:
0.91%

124 cases of eclampsia









Adeoye, I. A., Onayade, A. A., & Fatusi, A. O.
(2013). Incidence, determinants and perinatal
outcomes of near miss maternal morbidity in IleIfe Nigeria: a prospective case control study.
BMC Pregnancy and Childbirth, 13(93), 8-10.
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Casecontrol

Maternity units of Obafemi
Awolowo University
teaching Hospitals
Complex, Ile-Ife, Nigeria

July 2006—June 2007
*w/periods of interruption

Hypertensiv
e disorders
of
pregnancy =
37.3%
(n=28) of
near miss
cases
[severe

Fetal outcome: alive at discharge=59.2%; fresh stillbirth=18.3%’
macerated stillbirth= 14.7%; early neonatal death=7.7%
4154 maternal deaths out of 171,621 Maternal mortality ratio: 2420
per 100,000
Eclampsia was found to be the most important cause of maternal
deaths
“Phase I delay (delay in seeking appropriate treatment), in particular,
appears to be the rate-determining step along the non-biologic
pathway through which death precipitated by eclampsia occurs.”
Recommend training staff in detecting and referring women at risk for
eclampsia (as well as anemia and ruptured uterus) during pregnancy.






Maternal near miss was defined as “any woman who experienced a
life-threatening complication and who nearly died but for the hospital
care she received” and included cases of: haemorrhage, hypertensive
disorders in pregnancy, dystocia, infection, severe anemia.
Majority of near miss cases were not booked for ANC at tertiary facility
(70.7%) which was significantly different from proportion of controls
not booked for ANC at tertiary level (27. 0%)
37.3% of near miss morbidities caused by hypertensive disorders in
pregnancy
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PE=19(25.3
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eclampsia=
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Recommendations=




Adinma, E. D. (2012). Pattern of clinical
presentation of eclampsia at Nnamdi Azikiwe
University Teaching Hospital, Nnewi,
Southeastern Nigeria. Nigerian Journal of
Medicine, 21(3), 313–316.

Retrospecti
ve study of
cases of
eclampsia

Nnamdi Azikiwe University
Teaching Hospital, Nnewi,
Southeastern Nigeria
January 1, 2000—
December 31, 2009


Prevalence
of 0.91%




6,262 cases reviewed


Adinma, E. D. (2013). Maternal and perinatal
outcome of eclampsia in tertiary health
institution in Southeast Nigeria. Journal of
Maternal-Fetal and Neonatal Medicine, 26(2),
211–214.

Retrospecti
ve study of
cases of
eclampsia

Nnamdi Azikiwe University
Teaching Hospital, Nnewi,
Southeastern Nigeria

Prevalence
of 0.91%

January 1, 2000—
December 31, 2009

CFR: 8/46=
17.4%

6,262 cases reviewed







Agida, E. T., Adeka, B. I., & Jibril, K. A. (2010).
Pregnancy outcome in eclamptics at the
University of Abuja Teaching Hospital,
Gwagwalada, Abuja: a 3 year review. Nigerian
Journal of Clinical Practice, 13(4), 394–398.

University of Abuja
Teaching Hospital,
Gwagwalada, Abuja
Retrospecti
ve review
of case
notes

Case note review, of
patients with eclampsia
from May 1, 2005 and
April 30, 2008
4471 deliveries, 59
eclampsia cases, 46 case
notes available
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59 cases of
eclampsia;
incidence of
13 per
1,000
deliveries







CFR: 8.5%



Stillbirth
rate: 2 per
1,000
deliveries



Chronic hypertension found to have strongest association as a risk
factor for near misses (7 fold increase in risk).
Key determinants of near miss: phase I delay, chronic hypertension,
emergency caesarean section, and assisted vaginal delivery.
57 cases of eclampsia, but only 46 case files were complete and
included in the analysis.
Antepartum eclampsia= 35 (76.1%); intrapartum = 7 (15.2%);
postpartum = 4 (8.7%)
21 cases experienced three or more convulsions before treatment
was started, 9 cases had two convulsions, and 16 experienced one
convulsion prior to treatment.
Patients presented with: headache (74%), edema (71%), severe
hypertension (dBP >110mmHg) (69%), Blurring of vision (65%) and
unconsciousness (26%)
60.9% were nulliparous and 89% were unbooked
57 cases of eclampsia, but only 46 case files were complete and
included in the analysis. 71.7% of which were delivered by caesarean
section
Morbidities include: pulmonary edema (n=6), acute renal failure
(n=4), coagulopathy (n=3) aspiration pneumonitis (n-2),
cardiovascular accidents (n=2) and HELLP syndrome, septicemia and
cerebral edema occurred in 1 each.
Eight maternal deaths
Perinatal outcomes: 46 women delivered 51 babies (1 set triplets and
three sets twins). 82.5% were premature, and 70.6 had low birth
weight
13 perinatal deaths (25.5%)
At the time, this facility used the Zuspan regimen
Eclampsia was most common among 20-24 year olds (34.8%). 60.9%
of eclampsia cases were in women 20-29 years old
60.9% were primigravidae
22 (47.8%) had proteinuria of 3+, 3 (6.5%) had no proteinuria
20 were managed with diazepam and 19 were managed with MgSO4;
only three patients had recurrent seizures
39 were delivered by caesarean, 5 vaginally (1 of whom delivered
elsewhere and was referred when she developed eclampsia
postpartum), and 1 died undelivered.
Complications included: acute renal failure (6 patients) 3 of whom
died (though 5 maternal deaths due to eclampsia were recorded, the
case notes were only available for three).
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Study
Design

Retrospecti
ve review
of case
records

Bukar, M., Kunmanda, V., Moruppa, J., Ehalaiye,
B., Takai, U., & Ndonya, D. (2013). Maternal
mortality at federal medical centre yola,
adamawa state: a five-year review. Annals of
Medical and Health Sciences Research, 3(4),
568–571.

Retrospecti
ve study of
maternal
deaths

Buowari, Y. (2013). Pattern and Outcome of
Eclampsia Managed at a General Hospital in
North-West Nigeria. Nigerian Health Journal.

Retrospecti
ve study of
eclampsia
patients

Chigbu, B., Onwere, S., Kamanu, C., Aluka, C.,
Okoro, O., & E, A. (2009). Pregnancy outcome in
booked and unbooked mothers in South Eastern
Nigeria. East African Medical Journal, 86(6),
267–271.

Hospital
based
retrospecti
ve study

Ebeigbe, P., & Aziken, M. (2010). Early onset
pregnancy induced hypertension/eclampsia in
Benin City, Nigeria. Nigerian Journal of Clinical
Practice.

Retrospecti
ve study of
hospital
cases
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Location, Timeframe, and
Sample size

Federal Medical Centre,
Lokoja, Kogi
Jan 1, 2005 – December
31, 2009
44 maternal deaths
reviewed

Prevalence/

Main findings/ limitations

Incidence/
CFR

Conclusions/

Hypertensiv
e disorders
causes
31.8% of
maternal
deaths

Federal Medical Centre
Yola.
January 2007—December
2011

N/A

Recommendations=


37 babies were delivered alive, (6 of whom were <1500g; 14 were
2500g> but >1500g; and 16 were >2500g) 8 stillbirths





MMR during this period at the facility was 463 per 100,000 live births
PE/E accounted for 14 of the 44 maternal deaths
During the study period, MgSO4 was unavailable at the facility; since
its introduction at the center in Oct 2009, no one has died from PE/E



54 maternal deaths among 8497 deliveries: MMR= 636 per 100,000
deliveries; 33 files were retrieved and 28 were complete for analysis.
Leading cause of maternal death was PE/E (32.1% of 28)—all of those
who died of PE/E had not attended ANC, were Muslim and Hausa or
Fulani.



28 case files of maternal
deaths
General Hospital Aliero,
Kebbi state, Nigeria




December 2004 to
November 2006



58 records



Abia State University
Teaching Hospital, Aba,
Nigeria
January 1, 2005—
December 31, 2007
3,734 mothers who
delivered

University of Benin
Teaching Hospital, Benin
City, Nigeria

Incidence
(unbooked):
7.9%
Incidence
(booked):
2.0%
Overall
incidence:
3.0%









47 antepartum or intrapartum; 11 postpartum eclampsia
Of those 47, 31 (66%) were delivered by caesarean and 44 (75.86%)
survived and were discharged
37 babies survived, 6 were fresh stillbirths and 4 were caveated
stillbirths.
At the time of the cases, diazepam was the only anticonvulsant
available

Unbooked mothers had statistically higher incidence of PE/E (OR
3.88; 95% CI 2.61-5.77)
Eclampsia caused 9 deaths among unbooked women and 6 among
booked women
Unbooked mothers in this study were generally younger, with lower
educational status and higher probability of being unmarried.

Early onset pregnancy induced hypertension/eclampsia contributed
6.3% of all HDP cases (1 per 141 deliveries)
58.7% of HDP cases were delivered by caesarean section
Perinatal survival rate was 34.0%,
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Recommendations=
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Retrospecti
ve analysis
of medical
records

National Hospital, Abuja
March 1, 2000—February
28, 2005

Incidence
7.8 cases of
eclampsia
per 1000
deliveries
CFR= 28.3%







Eke, A. C., Ezebialu, I. U., & Okafor, C. (2011).
Presentation and outcome of eclampsia at a
tertiary center in South East Nigeria--a 6-year
review. Hypertension in Pregnancy, 30(2), 125–
132.

Ekele, B., Bello, S., & Adamu, A. (2007). Clusters
of eclampsia in a Nigerian teaching hospital.
International Journal of Gynecology and
Obstetrics, 96(1), 62–66.

Retrospecti
ve study of
case notes

Nnamdi Azikiwe University
Teaching Hospital, Nnewi,
Anambra state, Nigeria
2004-2009
212 case notes of
eclampsia patients

Usmanu Danfodiyo
University Teaching
Hospital, Sokoto, Nigeria
Retrospecti
ve cohort

Jan 1, 1995—December
31, 2004
Reviewed files of 15,318
deliveries over the period
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Prevalence=
1.57%
CFR 7.5%





Overall
prevalence:
4.29%



Incidence at
the
beginning of
the study
period:
0.39%
(1995) and
increased to
7.0% (2004)





This study suggests that aggressive management (stabilization and
early delivery) of early onset severe PE is associated with good
outcomes for mother but poor perinatal outcomes. Conservative
management should be only used in well-equipped facilities that have
the resources and capacity for close monitoring and urgent response.
Eclampsia occurred most often in unbooked, nulliparous mothers,
71.5% of cases were delivered by caesarean due to ‘unfavourable
cervix’
58.7% of cases occurred antepartum, 26.1% were postpartum and
15.2% were intrapartum
Diazepam was used to control fits, MgSO4 was only used in two
cases.
Hydrallazine was used to control hypertensive (particularly in ICU)
while Nifedipine and Methyldopa were used when BP was better
controlled
19 developed complications including (HELLP syndrome, acute renal
failure, disseminated intravascular coagulation, septicaemia, lobar
pneumonia, pulmonary edema, cerebral hemorrhage, cerebral
damage and quadriplegia.
13 maternal deaths, 46.2% due to HELLP syndrome

24.5% of eclamptic patients were unbooked
Most commonly affected women were nulliparous teenagers (60.4%).
Cesarean delivery accounts for 75.5% of all eclamptic deliveries
12 neonatal and 8 perinatal deaths

Cases were defined as “maternities that presented with fitting or fitted
while on admission, had blood pressure equal to or greater than
140/90 mmHg at least 2+ proteinuria with or without edema, and had
no past history of epilepsy.”
26.3% were antepartum, 67.3% were intrapartum and 6.4 were
postpartum. 95.4% patients were unbooked. 75.8% were primigravida
Incidence increased significantly over the study period with peaks
identified in 1996, 2001 and 2004. (Each is twice about twice the
expected/projected rate for that time.)
Factors that may have caused UDUTH to receive more cases of
eclampsia: it is the only tertiary facility in the area and would receive
more difficult cases and the facility’s participation in the Magpie Trial
meaning they had MgSO4 and clinicians in nearby facilities were
aware which might have encouraged selective referral of women PE/E
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Retrospecti
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302 cases of eclampsia

Incidence of
3.9%
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Fabamwo, A., Akinola, O., Tayo, A., Gbadegesin,
A., Kushemiju, O., & Oyedele, Y. (2007). SocioDemographic Characteristics of Eclamptic
Patients at a Tertiary Institution in Lagos Nigeria.
Nigerian Medical Practitioner, 52(4).

Retrospecti
ve review

Department of Obstetrics
and Gynaecology, Lagos
State University Teaching
Hospital, Ikeja, Lagos State
January 1, 1999—

Incidence =
1.66%
eclampsia




December 31, 2003

to UDUTH. Also many of the risk factors for PE/E are common in this
area.
Eclampsia occurred intrapartum in 55% of the patients
90% of cases experienced headache, blurred vision, and epigastric
pain prior to first seizure
dBP > 110 mmHg was recorded in 33.8%
66.9% were teenagers, 73.5% were primigravidae, spontaneous
vaginal delivery occurred in 52.6% (40.4% were caesarean section)
111 perinatal deaths (36.8%) (108 were due to eclampsia, the other
6 had congenital anomalies)
Of the 216 live births, 40% were preterm
Morbidities included: pyrexis (7.3%), postpartum hemorrhage (4.6%)
abruption (2.7%), and others at lower frequency

65.4% of cases were nulliparous, incidence was highest for women
under 30
Unbooked, young, nulliparous women were found to be most prone to
developing eclampsia, recommend targeting this group to attend ANC
regularly.

12,875 deliveries
Igberase, G., & Ebeigbe, P. (2006). Eclampsia:
Ten-years of experience in a rural tertiary
hospital in the Niger delta, Nigeria. Journal of
Obstetrics and Gynaecology, 26(5), 414–417.

Descriptive
review of
hospital
cases

Baptist Medical Centre
(BMC), Eku, Delta State
January 1, 1994—
December 31, 2003


Incidence of
eclampsia:
2.3%



123 cases of eclampsia



Baptist Medical Centre
(BMC), Eku, Delta State
Igberase, G., & Ebeigbe, P. (2007). Maternal
mortality in a rural referral hospital in the Niger
Delta, Nigeria. JOURNAL OF OBSTETRICS AND
GYNAECOLOGY, 27(3), 275–278.

Maternal
death audit



January 1, 1994—
December 31, 2003
5,153 deliveries, 115
maternal deaths



CFR: 15.4%
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17 (13.8%) of women with eclampsia were unbooked. Teenagers
accounted for 21.1$ of cases.
Most common symptoms were: headache (78%), blurring of vision
(57.7%), vomiting (29.3%), epigastric pain (19.5%), and dizziness
(55.3%)
68% of the patients began experiencing seizures antepartum, 23.6%
intrapartum, and 8.2% postpartum
MMR= 2,232 per 100,000 live births (booked: 420 per 100,000;
unbooked 4,123 per 100,000)
PE/E caused 20 (17.4%) of maternal deaths during this period, the
third most significant cause after puerperal sepsis (33%) and
abortions (22.6%).
Two thirds were delivers by CS, 25.2% by spontaneous vaginal delivery
and 8.1% (n=10) by instrumental delivery.
Mean systolic BP at presentation was 174 + 29.7 mmHg and mean
diastolic BP was 111.8 + 18.1 mmHg
19 maternal deaths
Perinatal mortality was 195 per 1,000 births
Recommend: community-based health education programs to
encourage667777654 early ANC, train TBAs and integrate them into
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Prospectiv
e hospital
case
review

Aminu Kano Teaching
Hospital, Kano, Nigeria
120 cases of eclampsia

Incidence of
eclampsia
1.2%
CFR: 11.7%




primary healthcare team, improve referrals and capacity of tertiary
institutions to provide intensive care for eclamptic patients.
65% were primigravidae, 83.7% were unbooked, 81.4% were under
30 years of age, mean age was 23.5 years
24 (55.8%) had eclamptic fits antepartum, 11 (25.6%) intrapartum
and 8 (18.6%) postpartum.
No fits occurred below BP of 150/90mmHg
100% were treated with diazepam; break-through seizures were
controlled with diazepam, and IV paraldehyde was used in one patient
who was not responding well to diazepam.
All 43 patients received Hydrallazine to control blood pressure
Rate of caesarean section was 85.7%,
Seven fetal deaths occurred (two due to low birth weight and asphyxia
and the other five were stillborn before arriving at the facility)
Health education, ANC, women’s awareness of obstetric services,
early diagnosis and treatment, protocols for management of fluid
balance, antihypertensive, and anticonvulsive therapies are necessary
to reduce morbidity, mortality and high rates of CS.
Maternal complications in eclamptic patients: prolonged
unconsciousness: 13 (10.8%); acute renal failure: 6 (5.0%),
cerebrovascular accident 5 (4.2%); HELLP syndrome: 5 (4.2%) and
others including: pulmonary oedema/pneumonia, coagulopathy,
abruptio placenta, cortical blindness, cardiomegaly, vesicovaginal
fistula
14 maternal deaths due to eclampsia
Perinatal outcomes in eclamptic mothers: stillbirth: 27 (22.5%), birth
asphyxia: 47 (39.1%); low birth weight: 31(25.8%); admission to
nursery: 19 (15.0%)
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Federal Medical Centre,
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December 31, 2007

N/A



112 case notes from
maternal deaths
State Specialist Hospital,
Bauchi, Nigeria




N/A





MMR 2,849 per 100,000 deliveries
Eclampsia persistently was the leading cause of death (46.4% of all
deaths during the period)
Grandmultiparas, illiteracy and lack of prompt ANC were significant
contributors in this study

MMR= 1,732 per 100,000 live births
81% of maternal deaths were in unbooked deliveries
Severe PE/E accounted for 31.9% (n-245) of maternal deaths
(followed by obstetric haemorrhage and sepsis)
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Descriptive
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Teaching Hospital, Nnewi,
Nigeria



January 2004—December
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3.7%
incidence of
hypertensive
disorders in
pregnancy.

4026 deliveries

CFR: 5.6%

January 1, 1997—
December 31, 2000






Specialist Hospital Gombe
Review of
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11,985 deliveries

Retrospecti
ve study

Federal Medical Centre
(FMC), Abakiliki and Ebonyi
State University Teaching
Hospital (EBSUTH),
Abakiliki and two mission
hospitals: Mile 4 Hospital,
Ishieke and Mater

Updating management policy for eclampsia and focus on increasing
quality of emergency obstetric care can help reduce maternal death
as well as use of magnesium sulphate and training providers from
referring facilities on how to use it. Improving blood banking and
transfusions can also help women in this community survive.
Each patient was categorized into three categories:
16 (41.02%) Severe PE: hypertension after 20th week,
dBP>110mmHg on admission, proteinuria >30mg/dl in random urine
specimen or > 300mg in 24hr
11 (28.2%) Imminent eclampsia: all parameters in (1) plus headache,
blurring of vision and upper abdominal pain
6 (15.4%) Eclampsia: all parameters in (1) and seizures.
Six perinatal deaths (13.95%) (among four cases), three early
neonatal deaths were a set of triplets. Overall perinatal mortality rate
attributable to a single disease entity (severe PE/E) was 5.84 per
1000 births
The author recommends that in this setting, the Pre-eclampsia
community Guidelines (PRECOG) would minimize incidence and
complications of ‘SPEE” (severe PE/E)
148 women managed for hypertensive disorders in pregnancy; 138
complete folders were available for analysis
64 (46.4%) had PE, 50 of whom had “severe” PE; 28 (20.3%) had
eclampsia; 7(5.1%) had Chronic hypertension; 14 (10.1% had chronic
hypertension with superimposed preeclampsia; 17 (12.3%) had
unclassified hypertension.
Booking status and severity of disease were important determinants
of maternal and neonatal outcome in this study






MMR 2058 per 100,000 deliveries
438 cases of eclampsia, 67.8% were teenage mothers, 79.8% were
primigravidas; 51.0% delivered vaginally
64.7% were live births and 35.3% stillbirths. Among women with
eclampsia, perinatal mortality was 2023 per 100,000 live births (due
to prematurity, intrauterine fetal death, and low birth weight)
134 maternal deaths of 14, 884 live births: MMR= 902.7 per
100,000 live births
30% of all deaths were 20-29 years old and 35.1% were grand
multiparous; overall 12 maternal deaths (12.4%) from PE/E
Most common cause of death at FMC was PE/E (30%)(n=3)
EBSUTH saw 2 (6.5%) maternal deaths from PE/E, Mile 4 Hospital had
2 (7.7%) and Mater Misericordiae Hospital had 5 (16.7%) maternal
deaths from PE/E
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Hospital, Abuja
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117 (42.2%) of maternal deaths were caused by eclampsia
CFR was slightly higher for women <20 years (36.2%), first delivery
(33.8%), no formal education (32.4%) no prenatal care (32.3%), and
Glasgow coma score of <5 at presentation (46.1%) (only Glasgow
coma score had a significant difference)
24.7% of perinatal deaths were due to eclampsia (61.5% of which
were from mothers who also died).
Educating women, promoting FP, ANC and delivery services, and
health education on feature of severe PE are measures that can help
reduce maternal death from eclampsia
816 patients admitted to ICU during period, rate of 2.8 per 1000
deliveries.
Nine were preeclamptic or eclamptic (which made up 50% of the
obstetric admissions) other obstetric admissions included: obstetric
haemorrhage, gestational diabetes.
Four of the PE/E cases admitted to the ICU died (44%) due to
cardiovascular collapse following multiple organ failure (n=3) and
cerebral haemorrhage (n=1).
This and other studies show that PE/E and obstetric haemorrhage are
the most common causes of obstetric admissions to the ICU
This study suggests that PE/E might benefit from preoperative
admission to ICU and invasive monitoring could help reduce mortality
40 eclamptics presented at the ICU during the study period, but
records for two were incomplete and not included in analysis; ICU
admission rate of 8.2 per 1000 live births. 32 (84.2%) of these
patients were unbooked for ANC.
4,857 deliveries, 4,854 live births, (5,051 total births, including
multiple births).
20 (52.6%) had antepartum eclampsia, 12 (31.6%) had postpartum
eclampsia, and six (15.8%) had intrapartum eclampsia
29 (76.3%) were delivered by caesarian section
Major complications included: HELLP syndrome, disseminated
intravascular coagulation, acute renal failure, and quadriplegia.
MgSO4 was unavailable at the time, ant all expect for one of the
patients received diazepam to control fitting.
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To lower BP, Hydrallazine was the preferred antihypertensive.
The main cause of death in this study was HELLP syndrome (n=5,
45%)

Ebonyi State University
Teaching Hospital,
Abakaliki




January 1—December 31,
2007



MMR=2735.6 per 100,000 deliveries
Severe PE/E accounted for 35.6 (n=16) maternal deaths
(haemorrhage caused 28.9% and sepsis caused 13.3% of maternal
deaths)
88.9% (n=40) of all maternal deaths were unbooked; improving ANC
attendance an help prevent development of severe PE/E and reduce
maternal death by detecting and managing pre-eclampsia early

1,646 deliveries


Okogbenin, S A et al. “Eclampsia in Irrua
Specialist Teaching Hospital: A Five-Year
Review.” Nigerian Journal of Clinical Practice
13.2 (2010): 149–153.
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78 cases of eclampsia




Okusanya, BO et al. “Maternal Deaths: Initial
Report of an on-Going Monitoring of Maternal
Deaths at the Federal Medical Centre Katsina,
Northwest Nigeria.” Journal of Maternal - Fetal
and Neonatal Medicine 26.9 (2013): 885–888.

Review of
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Department of Obstetrics
and Gynaecology, College
of Medicine, University of
Lagos
June 1, 2008—May 31,
2012




(no full text available, but was able to extract relevant details from
Abstract)
Eclampsia accounted for 2.52% of admissions to the labor ward; case
notes available for 74 cases.
All except four were unbooked and over half (54.29%) of those
unbooked cases had not received any ANC.
Patients experienced: headache (74.32%), blurred vision (21.62%),
restlessness (16.22%), nausea (10.81%) and vomiting (10.81%).
Perinatal mortality = 28.38%, maternal mortality= 22.97%

MMR = 827 per 100,000 live births, PE/E was the second most
common direct cause of maternal death (n=14, 18.9%)
Among teenagers (23.5% of deliveries), PE/E was the most common
cause of maternal death, accounting for 37.5%



68 maternal deaths

Nigeria
Oladapo O, Adetoro O, Ekele B, Chama C, Etuk
S, Aboyeji A, et al. When getting there is not
enough: a nationwide cross-sectional study of
998 maternal deaths and 1451 near-misses in
public tertiary hospitals in a low-income country.
BJOG An Int J Obstet Gynaecol [Internet]. 2015
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2013
42 hospitals in six
geopolitical zones






2,449 SMO cases


74

Identified all cases of severe maternal outcome (SMO): maternal nearmiss (1451) or maternal death (998).
91, 724 live births, MMR at participating facilities was 1088 per
100,000 live births, maternal near-miss was 15.8 per 1,000 live
births, and SMO ratio was 26.7 per 1,000 live births.
Hypertensive disorders (chronic hypertension and PE/E) were the
most common complication and caused 24% of SMOs
Eclampsia was the most frequent complication and accounted for 1/5
maternal deaths.
About half women experiencing organ dysfunction due to hypertensive
disorders in pregnancy, died—effort is needed to reduce maternal
mortality by promptly managing organ dysfunction resulting from HDP.
Overall, the median time interval to initiating “definitive
treatment/intervention’ was 60 minutes, but in 47.4% of SMO cases,
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Incidence
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CFR: 20.4%




93 cases of eclampsia



Primary, secondary and
tertiary facilities and 123
private facilities in Ogun
State


N/A



the delay was over an hour and in more than 1/5 cases it was over
four hours
The research team identified deficiencies in management of almost
half SMO cases (1215, 49.6%)
Contributors to substandard care included: late presentation to
hospital, inability to pay/no insurance, unavailability of blood products
75 maternal deaths and 2509 live births; MMR= 2989.2 per 100,000
live births
Hypertensive disorders in pregnancy (severe PE/E) caused 28% of the
maternal deaths, (eclampsia: 24%, severe PE, 4%)
Nine women died from complications due to severe PE/E before
delivery; these complications were: cerebrovascular accident (n=8)
and acute renal failure (n=1).
Up to the end of the study period, MgSO4 had not been adopted for
treating severe PE/E and was unavailable
MMR= 963 per 100,000 live births
14 (16.7%) maternal deaths caused by eclampsia; 64.2% of these
were among women under 25 years old
71.4% of deaths due to eclampsia were in nulliparous women, 85%
occurred within 24 hours of being admitted, 71.4% were unbooked,
and more deaths due to eclampsia were seen during the rainy season
5,423 deliveries over the study period and 92 maternal deaths, 19 of
which were caused by eclampsia.
82 cases were antepartum, eight were intrapartum and three were
postpartum, 94.7% of deaths were in antepartum cases.
93 cases of eclampsia, all patients received diazepam to control
convulsions and hydralazine (antihypertensive) when needed.
96.8% were unbooked, 60.2% were delivered by caesarean section,
and 78.5% were nulliparous
Nulliparous teenagers were the most at risk of dying from eclampsia
n=38)
87 were antepartum, 4 were intrapartum and 2 were postpartum
(*conflicts with previous paper published on these data, above)
Using a one-page form, researchers collected the data elements they
required to calculate various neonatal, perinatal, infant, under-five
and maternal mortality rates.
MMR= 177.6 per 100,000 live births
Eclampsia accounted for 9 of the 37 maternal deaths
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15 women who died
undelivered

8 of the 9 deaths caused by eclampsia were unbooked/unregistered
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37 maternal deaths
Omo-Aghoja, L., Aisien, O., Akuse, J., &
Okonofua, F. (2010). Maternal mortality and
emergency obstetric care in Benin City Southsouth Nigeria. Journal of Clinical Medicine and
Research, 2(4), 55–60.

Recommendations=







84 maternal deaths, MMR= 2,282 per 100,000 deliveries,
113 cases of eclampsia were managed
18 (21.4%)(*there was a typo in the table, it says 12.4%) of the
maternal deaths were due to “severe pregnancy induced
hypertension/eclampsia”
Recommends improved emergency obstetric services
Five facilities were included: University of Nigeria Teaching Hospital
(UNTH), the Mother of Christ Specialist Hospital (MOCSH), Parklane
Specialist Hospital (PSH), Bishop Shanahan Hospital (BSH), and
Ntasiobi Ndi No N’afufu Hospital
Overall MMR= 772 per 100,000 (UNTH was the worst with an MMR of
2,283 per 100,000 and MOCSH had only 192 per 100,000)
Only complete folders were retrieved for 89 (63.1%) of the maternal
deaths.
PE/E caused 15 of the 89 maternal deaths (16.9%)
32deaths out of 7,055 deliveries, MMR= 454 per 100,000
34.4% (n=11) of maternal deaths were due to eclampsia; this was the
most significant cause of maternal death followed by sepsis and PPH
at 18.8% each
This study presents some case scenarios of maternal deaths, two
related to PE/E:
--One woman, 32 years old, para 2, with PE arrived at the UBTH after
being referred from a private maternity home, after two convulsions,
she died before she could deliver
--A 25 year old woman with severe PE (BP 181/130mmHg) declined
admission, went home to update her husband and returned later but
died shortly after re-admission
53 maternal deaths out of 10,572 deliveries; MMR= 501 per
100,000
Incidence of dying undelivered = 141 per 100,000 deliveries
Severe PE/E contributed six (40%) of the undelivered deaths, followed
by ruptured uterus (n=4, 26.7%)
Two of the eclampsia patients were grandmultiparae, poor, and
illiterate.
Seven of the fetuses survived and six of them were in patients with
eclampsia.
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Recommendations include: health education for would-be clients,
improve content of ANC, improve obstetric emergency capability at
facility, establish materno-fetal medicine unit and awareness and
policy relating to postmortem caesarean section





MMR= 652 per 100,000 (including abortion deaths)
Nulliparity and unbooked had the highest rates of maternal mortality.
Eclampsia contributed 17 maternal deaths (36.95%)



Antepartum eclampsia occurred in 60% of cases, 31.3% had
intrapartum and 8.7% postpartum
The most common symptoms were: headache (100%), hypertension
(88.88%) and fever (42.22%).
Diazepam successfully controlled fits in 66.6% of patients
19 maternal and 20 perinatal deaths
Recommendations include: standard plan for managing eclampsia
and distributed as guides to all hospitals, ANC and delivery services
must improve and provide quality surveillance of women and
identification of women at risk of eclampsia, intensive care facilities
are needed to treat women experiencing acute renal and
cardiopulmonary complications.
Eclampsia was determined to be the probable cause of death in 8
(33.3%) of the brought-in maternal deaths
Common reasons for late presentation to the hospital include: inability
to obtain transit (41.7%), inability of health care staff to detect
problems early enough (33.3%), inability of referring hospital to
perform emergency C-section (25%), unavailability of blood for
transfusion( 25%), unwillingness of drivers to travel at night (25%),
and no money to pay for hospital fees (16.7%)
One woman had suffered from eclampsia at 38 weeks gestation and it
took her husband some time to collect the money for transit and
hospital fees. She was carried on a motorcycle for 10km to the closest
place to get on a vehicle to the facility. She had to wait for the vehicle
to arrive and died on the way before arriving at the hospital.
MMR= 1936.1 per 100,000 = 103 maternal deaths out of 5320
deliveries, 86.4% of which were due to obstetric causes
Eclampsia accounted for13 (12.6%) of all maternal deaths and
pregnancy induced hypertension caused 5 (4.9%)
Blood banking, improved access to healthcare services and
empowering women can reduce maternal deaths.
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Eclampsia contributed to 43.1% (n=22) of all maternal deaths and 27
(13%) perinatal deaths
56% of patients experienced delay before reaching hospital.
58.5% were <20 years old, 78.3% were primigravida, and 51.7% were
delivered by cesarean section
Eclampsia manifested antepartum in 32.9% (n=69), intrapartum in
54.1% (n=112) and postpartum in 12% (27).
Recommends health education for community members to increase
awareness of the importance of ANC
Adolescent= 10-19 years old
25 maternal deaths among study population, Adolescent MMR= 547
per 100,000 deliveries
Eclampsia and Sepsis each caused 5 deaths, accounting for 26.3%
each of the overall adolescent maternal deaths.
267 maternal deaths out of 38,768: MMR 740 per 100,000
deliveries
Eclampsia accounted for 75 (23.6%) of all maternal deaths.
Eclampsia ranked third most common direct cause of maternal death
after Haemorrhage (34.6%) and sepsis (28.3%)
An indirect cause of maternal mortality was acute renal failure (8%)
which is a complication of eclampsia.
127 women died out of 13,943 deliveries ; MMR= 904 per 100,000
Eclampsia contributed 28.57% of all maternal deaths.
Perinatal mortality among eclamptics was 132 per 1000 eclamptic
deliveries. 6.2% were fresh stillbirths, 3.5% were macerated stillbirths,
and 3.5% were not delivered.
50.14% of the patients were teenagers (10-19 years old)
82.3% were primigravidae, 48.5% received some ANC (mostly from
primary health centers)
44.9% developed convulsions antepartum
83.3% presented within 12 hours of the first convulsion and
outcomes are made worse by delay in presentation.

